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1. Abstract  
 
The genetic information is identical within the organism but the mechanisms by which 
different cell types achieve specialized functions interpreting the same set of instructions is 
not completely understood. It is now increasingly accepted that the combination of 
different genomic elements, both promoters and enhancers, favors the recruitment of 
different TFs, which in turn promotes the assembly of different pre-initiation complexes, 
guaranteeing heterogeneity in transcriptional outputs across different tissues. Nevertheless, 
the cis-regulatory elements and the transcriptional rules that control and maintain the 
expression of constitutively active genes are still poorly characterized. Specifically, 
whether the constitutive activity of promoters and enhancers relies on entirely distinct or 
instead shared regulators is unknown. By dissecting the cis-regulatory repertoire of 
macrophages, we found that the ELF subfamily of ETS proteins selectively bound within 
60 bp from the transcription start sites of highly active housekeeping genes. ELFs also 
bound constitutively active, but not poised macrophage-specific enhancers and promoters. 
The role of ELFs in promoting constitutive transcription is suggested by multiple 
evidences: ELF sites enabled transcriptional activation by endogenous and minimal 
synthetic promoters; ELF recruitment was stabilized by the transcriptional machinery, and 
ELF proteins mediated recruitment of transcriptional and chromatin regulators to core 
promoters. These data indicate that a distinct subfamily of ETS proteins imparts high 
transcriptional activity to a broad range of housekeeping and tissue-specific cis-regulatory 
elements, which is consistent with the role of an ETS family ancestor in core promoter 
regulation in a lower eukaryote. 
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2. Introduction 
 
2.1 Generality on the transcription process 
 
A fundamental issue in biology is how cell-type-specific gene expression program is 
carried out by RNA polymerase II (RNA pol II) across different tissues.  
Transcriptional control of gene expression is a highly coordinated process that is regulated 
in time and space by the interplay of sequence-specific transcription factors (TFs), the 
transcriptional machinery, co-activators and co-repressors (Kadonaga, 2004). Nucleosome 
occupancy and epigenetic modifications, such as histone modifications, DNA methylation 
and RNA interference are other players of gene transcription since they alter the chromatin 
accessibility and consequently the TFs binding. These types of modifications occur both 
on genes and on regulatory elements, therefore the control of gene expression is not 
circumscribed at gene levels but involves also distal regulatory regions.   
Transcription of eukaryotic protein-coding genes begins with the binding of TFs to 
genomic regulatory elements, which in mammalian genomes are located right upstream 
and downstream of the transcription start site (TSS) both at gene promoters and at distal 
regulatory elements, specifically enhancers (Bulger and Groudine, 2011).  
 
2.1.1 Assembly of the transcriptional machinery 
 
Gene transcription is a well-controlled multi-step process that requires the pre-initiation 
complex (PIC) assembly to the core promoter, the region necessary to direct accurate 
transcription initiation (Sandelin et al., 2007). The PIC formation is triggered by the 
interaction of TFs and their cognate binding sites at proximal and distal regions and 
necessitates the presence of general transcription factors (GTFs): TFIIB, TFIID, TFIIE, 
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TFIIF, TFIIH and TFIIA (Reese, 2003). The multi-subunit TFIID is composed by TATA 
binding protein (TBP) and other 14 TBP-associated factors (TAFs), it interacts with TATA 
box, the initiator sequence and the downstream promoter element (DPE) (Hoey et al., 
1990; Verrijzer et al., 1995). This is a largely simplified view that derives from initial 
mechanistic studies performed on TATA box promoter. In 1991 Pugh and Tjian proposed 
two distinct roles for TBP and TAFs: while the former is involved in the PIC assembly, the 
latter integrate regulatory signals (Pugh and Tjian, 1991). Nevertheless, evidences suggest 
that TAFs are not simply auxiliary proteins but conversely they confer stability to the 
TFIID complex, for example TAF4 rather than TBP stabilizes the complex. Indeed, Wright 
et al., reported that TAF4, TAF5, TAF6, TAF9 and TAF12 form the stable TFIID core 
sub-complex whereas TAF1, TAF2, TAF11, and TBP are peripheral subunits (Wright et 
al., 2006).  
As anticipated before, the classical view of unique transcriptional machinery required to 
transcribe all genes was discredited by the existence of TATA-less promoters and by the 
discovery of tissue-specific TAFs and TBP-related factors, such as TRF1, which can 
recognize both TATA-containing and TATA-less promoters (Muller et al., 2007). This 
finding raises the possibility that the basal transcriptional machinery is not identical across 
different cell types and that different TFIID complexes can nucleate on distinct core 
promoters (Haberle and Lenhard, 2016). Therefore, it is likely that the stable TFIID core 
complex can interact with combination of other TAFs and TBP generating a large variety 
of structurally and functionally different PICs (Fig. 1) (Wright et al., 2006).  
Despite the variability in TFIID complex composition, its mechanism of action is identical 
in different promoters recognizing core promoter elements. Indeed, TFIID causes DNA 
bending through a 90° angle and recruits the other GTFs. TFIID binding is stabilized by 
TFIIB that subsequently recruits RNA pol II, together with TFIIF (Sainsbury, et al., 2015). 
Alternatively to this classic stepwise PIC assembly, TFIID can directly interact with 
Mediator Complex favoring the recruitment of the others PIC components (Allen and 
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Taaties, 2015).  
 
 
 
Figure 1. Schematic representation of TFIID recruitment on different promoters.  
In all three examples, different TAFs are involved in TFIID positioning on different promoters.  
(a) The TFIID complex recognizes the Inr and DPE sequences via TAF1/TAF2 and TAF6/TAF9 
respectively. (b-c) TFIID complex is recruited through the interaction between TAF1 and DCE subelements 
(DCEI, DCEII and DCEIII). Adapted from (Lee et al., 2005)  
 
TFIIB could assume different conformations depending on the presence or absence of 
TFIIB recognize elements (BRE) in the promoter. These conformational changes are 
responsible for the TFIIB ability to stabilize TBP to DNA (Reese, 2003).  
The PIC formation concludes with the recruitment of TFIIE and TFIIH, which catalyzes 
ATP-dependent melting of the promoter at the TSS, generating an open region of about 15 
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base pairs, and allowing the progression into the elongation phase of transcription (Fazal et 
al., 2015). TFIIA is not a basal GTFs since it has the ability to potentiate the magnitude of 
the transcription aiding TBP binding (Hieb et al., 2007).  
In in vitro transcription assay, the PIC complex is sufficient for basal transcription but it is 
not sufficient to increase or in general to vary transcription rates in response to TFs. 
Regulated transcription in fact requires molecular bridges between TFs and the basic 
transcriptional machinery, the most relevant one being Mediator (Malik and Roeder, 
2010). 
 
2.1.2 Core promoter elements 
 
As already mentioned, the core promoter is the platform in which the transcription 
machinery is assembled. It can be constituted by one or more conserved DNA sequence 
elements, which are not universal and are not essential for promoter function. The 
mammalian promoters can be characterized by the combination of different motifs or by 
the lack of known core promoter elements (Juven-Gershon et al., 2008) and, once that the 
RNA pol II initiation complex is recruited to cis regulatory elements, transcription can 
initiate at a variety of different positions (Carninci et al., 2006; Frith et al., 2008; 
Kadonaga, 2012; Forrest et al., 2014). TATA box, initiatior (Inr), TFIIB recognition 
element (BRE), DPE and downstream core element (DCE) are the most well known 
elements that are shared by different protein-coding genes and that have positional 
constraints in relation to the TSS (Kadonaga, 2012). Conversely, motif ten elements 
(MTE), x core promoter element 1 and 2 (XCPE1 and XCPE2) are additional elements that 
occur at lower frequency (Fig. 2) (Danino et al., 2015). 
TATA box. In metazoan the TATA box (Lifton et al., 1978), the first core promoter 
element identified, has a consensus of TATAWAAR that is constrained to a narrow 
window in which the 5’ T is located 34-28bp upstream the +1 A (or +1 G) of the initiatior 
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sequence (Juven-Gershon et al., 2008). The TATA-TSS spacing is relevant to achieve 
transcription, generally the optimal position is within -31 and -30bp from TSS, whereas 
TATA motifs located nearly to the TSS (downstream -28bp) are non-functional (Ponjavic 
et al., 2006). TATA box is found out in less then 15% of metazoan promoters (Haberle and 
Lenhard, 2016), mainly upstream the TSS of tissue specific and inducible genes.  
Initiatior. The Inr sequence (Smale and Baltimore, 1989) is a highly degenerate sequence 
whose only essential component is the Pyrimidine / Purine dinucleotide at the -1 / +1 
position, which represents the preferred context for transcription initiation by RNA Pol II 
in mammalian genomes (Carninci et al., 2006; Frith et al., 2008). The Inr sequence can 
independently direct accurate transcription initiation interacting with two subunits of the 
TFIID complex (TAF1 and TAF2) (Haberle and Lenhard, 2016). The pyrimidine-purine 
dinucleotide shows strong conservation and plays a key role for the transcription event 
(Carninci et al., 2006). Deletion of the dinucleotide of the human ankyrin 1 promoter 
causes the abolition of TFIID binding and the reduction of promoter activity (Gallagher et 
al., 2005). 
BRE. Upstream and downstream the TATA box are located two BRE motifs (BREu and 
BREd) (Deng and Roberts, 2005; Lagrange et al., 1998), which are involved in the TFIIB 
recruitment (Kadonaga, 2012) and, depending on the context, can influence transcription 
both in positive or negative manner (Danino et al., 2015). TFIIB mutation causes a shift in 
the initiation of transcription suggesting that it could be involved in the RNA pol II 
positioning (Deng and Roberts, 2007).  
DPE. DPE is another conserved sequence located +28,+30 bp downstream the TSS that 
functions cooperatively with the Inr sequence recognizing TAF6 and TAF9 (Burke and 
Kadonaga, 1997). Studies revealed that the distance between DPE and the Inr sequence is 
critical for the TFIID binding and basal transcription activity. TFIID binding, and 
consequently the transcriptional activity, is reduced by insertion of deletion of single 
nucleotide between the DPE and Inr sequence (Kutach and Kadonaga, 2000). It is possible 
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that DPE is involved in pausing the RNA pol II since its location and consensus sequence 
is similar to those of a Drosophila sequence, the “Pause Button”, which is associated with 
stalled polymerase (Kadonaga, 2012). 
 
 
Figure 2. Schematic overview of known core promoter elements.  
Depiction of some core promoter elements, which are found in only a fraction of all promoters (there are not 
universal core promoter motifs). Adapted from (Kadonaga, 2012). 
 
Others core promoter elements. An additional downstream element that has a critical 
spacing requirement with the Inr sequence is the MTE motif, which is located +18 to +27 
bp from the TSS (Danino et al., 2015).  
The DCE element consists of three sub-elements located +6 to +11, +16 to +21 and +30 to 
+34 downstream to the TSS, it generally occurs with the TATA box (Juven-Gershon et al., 
2008). Whereas DPE and MTE interact with TAF6 and TAF9, DCE has the peculiarity to 
recognize TAF1 subunit.  
The XCPE1 and XCPE2 are two additional core promoter elements that are found in 
human genes with low frequency (approximately 1%), they are both localized around the 
TSS but they differ for the ability to drive transcription; whereas the XCPE2 is able to 
initiate gene expression without additional TFs, XCPE1 acts in conjunction with co-
activators (Danino et al., 2015).  
Another motif that encompasses the TSS is the polypyrimidine initiator motif (TCT), it has 
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a sequence similar to the Inr sequence but it is enriched and functional in the promoters of 
ribosomal protein genes and of proteins involved in the regulation of translation 
(Hariharan and Perry, 1990; Parry et al., 2010). However, even if the Inr sequence and 
TCT motif seem to be related, TCT cannot substitute the Inr sequence for basal 
transcription activity (Kadonaga, 2012) since it does not interact with the canonical 
TBP/TFIID but rather with the TBP-related factor 2 (TRF2) (Wang et al., 2014).  
Recently, in the Dikstein lab a new downstream core element DTIE (Downstream 
Transcription Initiation Element) was identified in the miR-22 TATA-less and Inr-less 
promoter. DTIE is strictly localized, from +21 to +25 bp downstream the TSS, and it 
seems to control the precise TSS positioning and promoter strength cooperating with an 
upstream element DUCE, located between -111, -137 bp from the miR-22 TSS (Marbach-
Bar et al., 2016). Therefore, this work suggests an unprecedented complexity of the 
transcription initiation, namely the TSS selection does not depend only on the core 
promoter elements but instead also distal regions can be involved in the positioning of the 
transcriptional machinery. 
 
ETS site is located within 10-20 bp from the TSS 
Studies unveiled that also the core promoter context is relevant for the transcription by 
specific activators. In mouse, for example, Elf-1 protein is able to activate selectively Inr-
containing promoters with or without TATA box but not a TATA-only promoter (Ernst et 
al., 1996; Garraway et al., 1996). Similarly, Caudal factor in Drosophila activates 
preferentially DPE containing promoter but it does not activate TATA promoter with the 
upstream BRE motif (Juven-Gershon et al., 2008; Shir-Shapira et al., 2015). Moreover, 
Barbash and colleagues showed that core promoter elements have their unique but 
dispensable transcription activity. They introduced transgenes derived from the MHC class 
I gene carrying mutations in distinct core promoter elements into different mice. The 
promoter of MHC class I gene, ubiquitously expressed but subjected to tissue-specific 
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regulation, is characterized by four motifs (CAAT, TATAA-like, Inr and Sp1BS). Single 
mutation of each motif revealed that they are not necessary for the promoter activity in 
vivo but that each of them alters the wild-type patterns of gene expression in different 
tissues. However, it is not known if this is a characteristic of few genes or is a more 
widespread feature (Barbash et al., 2013). 
Genome-wide analysis, performed examining the distribution of 8-mers respect the TSS on 
Drosophila and human core promoters, uncovered that some sequences are not randomly 
localized (FitzGerald et al., 2006). Fitzgerald et al. reported that 9 sequences are 
predominantly associated with human core promoters, raising the possibility that they 
could be involved in transcription. 7 of these sequences are known TF binding sites 
(CCAAT, SP1, USF, CREB, TATA, NRF-1 and ETS), the other two motifs are the 
KOZAK sequence, which is located at 3’ of TSS, and an author-defined “CLUS1” 
sequence which doesn’t match with already known TFBS. Additionally, they found out 
that the ETS motif is one of the most common non-directional site (namely the 
transcription can occur on both DNA strands) usually located within 10-20 bp from the 
TSS of housekeeping genes (HK) (FitzGerald et al., 2004). In contrast, the TATA box, 
which is stranded specific, is more represented in the promoters of tissue-specific and 
highly regulated genes. Supporting this finding there is also the evidence that TATA box 
never occurs in the ETS containing promoters, suggesting their involvement in totally 
different roles (FitzGerald et al., 2004). Therefore, the core promoter architecture varies 
among genes guaranteeing a huge variability in the protein-coding gene expression across 
tissues. Despite the huge variability in the core promoter composition, the recruitment of 
the transcriptional machinery is maintained and accomplished by TFIID. Conversely from 
what was thought in the past, namely that there was only one universal and highly 
conserved pre-initiation complex (Thomas and Chiang, 2006), nowadays it is accepted that 
different TFIID subunits recognize different core promoter elements. Additionally, TBP-
related factors (TRFs) and cell-type specific TAFs enhance the variability in the 
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transcriptional machinery complexes recognizing different promoters. For example, in 
TRF2 knockdown mice the transcription of multiple post-meiotic and testes-specific genes 
is impaired causing defects in the spermatogenesis (Zhang et al., 2001; Martianov et al., 
2001). 
However, the mechanism of transcription initiation from TATA-less promoters or from 
promoters that does not contain any known core promoter elements remains to be 
determined. TF binding sites (TFBS) for Specificity protein 1 (Sp1) and Nuclear factor 
Y(NF-Y) have been found to be present in TATA-less and CpG island promoters (Pugh 
and Tjian, 1991; Yang et al., 2007). Moreover, few transcription factors have been shown 
to initiate transcription themselves, like the basic helix-loop-helix/leucine zipper 
(bHLH/ZIP) family of proteins and the ETS family members (Zhang et al., 2013). 
  
2.1.3 Dissection of different promoter types 
 
The variability of the core promoter influences two crucial aspects of the transcription 
event: the RNA pol II positioning, which in turn is critical for the transcription initiation 
(Kadonaga, 2012), and the assembly of different components of the transcriptional 
machinery on distinct promoters, which impacts on the interaction between enhancers and 
promoters and thus on gene regulation (Juven-Gershon et al., 2008). Different type of 
promoters can be identified considering PIC recruitment, function of associated gene, CpG 
content and nucleosome positions. 
TSS pattern and PIC recruitment. Promoters can be characterized by focused or 
dispersed TSSs depending on the RNA pol II positioning. In a canonical focused promoter, 
TFIID interacts with TATA box, Inr sequence and DPE and recruits in a well-defined 
position the transcriptional machinery. In this scenario there is a single TSS, or a cluster of 
start sites in a short region of few nucleotides, approximately 30 bp downstream the TATA 
box. By contrast, dispersed promoters are characterized by multiple TSSs across a region 
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of up to 150 bp. Different scenarios have been hypothesized to explain dispersed 
promoters. It is likely that different PICs can bind to slightly different sites, and thus 
dispersed promoters are depicted by the absence of a strong core promoter in which the 
transcriptional machinery recruitment depends on the interaction between TFs and 
Mediator proteins. Therefore, since promoters have multiple TF binding sites, the RNA pol 
II can be recruited on different positions, and the transcription can start in different sites, 
depending on which TF interacts with Mediator Complex (Sandelin et al., 2007; Goodrich 
and Tjian, 2010).  
Otherwise, it is possible that one PIC can slide to different sites to start separate initiation 
events, or that distinct TSS represent single TSS specific to each cell, that appear as 
dispersed in a cell population (Kawaji et al., 2006).  
Function of associated gene. It is thought that focused promoters regulate the 
expression of tissue-specific and inducible genes which required a tightly and controlled 
regulation, whereas housekeeping genes, that are ubiquitously expressed and required a 
less stringent regulation, are characterized by dispersed promoters which guarantee a 
steady level of transcription across cell types. However, also developmental genes are 
associated with dispersed promoters (Carninci et al., 2006).  
CpG content. In mammals dispersed promoters, relative to focused promoters, are 
characterized by CpG islands (CpGi), regions of around 1000 bp characterized by high C 
G content (Deaton and Bird, 2011). These promoters, enriched by CpG dinucleotides can 
be reversibly methylated, resulting in an alteration of the transcriptional state (Pugh and 
Venters, 2016). Nevertheless, genome-wide analysis of Drosophila promoters, which are 
CpG islands deficient, revealed that there is not a link between dispersed promoters and 
CpG island, whereas the presence of different core promoter elements can be used to 
discriminate focus from dispersed promoters. TATA-box, Inr, DPE and MTE, which have 
a defined position relative to the TSS, are commonly found in focused promoters (Haberle 
and Lenhard, 2016).  
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Nucleosome positioning. Focused and dispersed promoters are also distinguished 
by the nucleosome positioning (Bhatt et al., 2012; Ramirez-Carrozzi et al., 2009).  
Whereas dispersed promoters exhibit well positioned nucleosome, a higher degree of 
chromatin architecture, and therefore the requirement of nucleosome remodeling complex, 
focused promoters have a less stringent organization (Rach et al., 2011). In both cases 
promoters are characterized by the presence of a nucleosome free region (NFR), as 
suggested by the occurrence of DNase I hypersensitive site, which is flanked by two 
nucleosomes in a well-defined or less stringent position depending on the promoter types 
(Hesselberth et al., 2009; Rach et al., 2011; Lenhard et al., 2012).   
Therefore, promoters can be classified in three different types depending on the TSS 
patterns, the nucleosome positions, and their histone modifications, and the function of the 
associated gene (Lenhard et al., 2012). 
Type I promoters are focused promoters with a sharp TSS, they are devoid of CpG islands 
and have core promoter elements in a well-defined distance from the TSS (Roider et al., 
2009). They are characterized by low-ordered nucleosomes and regulate tissue specific 
genes (Rach et al., 2011).  
Type II promoters have multiple TSS dispersed in a NFR, which is flanked by two 
nucleosomes marked with H3K4me3, they are associated with weak core promoter 
elements and in mammals have a single CpG island (Lenhard et al., 2012).  
Type III promoters, similarly to type II, are characterized by multiple TSS and well-
positioned nucleosomes, but conversely from type II, have multiple CpG islands and 
nucleosomes are associated with repressive marks. The presence of polycomb group 
proteins on type III promoters is required to ensure a tight regulation of developmental 
genes (Hoskins et al., 2011). 
Another layer of complexity in the promoter identification comes out with the discoveries 
that many genes can be transcribed with multiple (or alternative) promoters (Davuluri et 
al., 2008) and can use different TSSs in oocytes and in somatic cells (Haberle et al., 2014). 
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Regarding the first point, the transcription is carried out in a context, or tissue-specific, 
manner by more than one promoters generating complexity and diversity in the 
mammalian transcriptome (Sandelin et al., 2007). It is thought that different combinations 
of core promoter elements, and therefore the recruitment of distinct transcriptional 
machineries, could modulate the transcription of multiple promoters (Haberle and 
Lenhard, 2016). The usage of different TSSs in the oocytes or somatic cells of zebrafish 
developing embryos seems due to the usage of different core promoter elements. Maternal-
specific TSS selection is driven by the oocyte-enriched transcription nucleating factor 
(Tbpl2) which recognizes the W-box motif, an A/T-rich region located 30 upstream the 
TSS. Conversely, the zygotic TSS selection is related to the stable position of the first 
nucleosome, which generates an area within which transcription can start (Haberle et al., 
2014). All these evidences suggest that the variability of core promoter composition has a 
striking role in the regulatory mechanisms that govern expression. Therefore, transcription 
depends on both the combined activity of TFs, expressed in spatial and temporal manner, 
and on the core promoter elements. 
 
2.2 Macrophage: a model to study gene regulation 
 
Macrophages are essential components of innate immunity that play a key role in host 
defense mechanisms against invading pathogens, in responding to injury and in 
maintaining the homeostasis of the body (Qiao et al., 2013).  
To quickly adapt to environmental changes caused by infections or tissue injuries, 
macrophages have the ability to alter their gene expression profile. Only few hours of 
bacterial lipopolysaccharide (LPS) stimulation are sufficient to generate a massive 
reorganization of chromatin and transcription, which results in the alteration of the 
expression of several hundred genes. Therefore, macrophages constitute a dynamic system 
that has been largely characterized. 
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Cell-type specific gene expression program is controlled in spatiotemporal manner by 
mutual interplay of promoters and regulatory elements, such as regulatory promoters and 
distal-promoter regions, which mediate RNA pol II regulation and recruitment of TFs 
(Zhou et al., 2011). 
Different histone modifications can mediate gene-specific transcriptional regulation 
allowing TFs binding to their target site and changing DNA accessibility to the 
transcriptional machinery (Zaret and Carroll, 2011). Histone marks change the higher-
order chromatin state, passing from an open and transcriptional active region 
(euchromatin) to an highly compact and transcriptional silent chromatin (heterochromatin) 
or vice versa. Therefore, since these two states depend on chromatin modifications, histone 
marks allow defining a priori if a gene is active or silent (Kouzarides, 2007; Baylin and 
Schuebel, 2007).  
Studies of regulatory elements in macrophages and B-cells have indicated that genes 
activated by identical stimuli differ extensively among the two cell types, even though 
induction of these genes depends on TFs (like NF-kB and AP-1 family members, for 
inflammatory stimuli) that are ubiquitously expressed. This ‘‘context dependence’’ seems 
to depend mainly on the existence of a cell type specific repertoire of functional cis-
regulatory elements, particularly enhancers (Heinz et al., 2015). 
 
2.2.1 Transcriptional regulatory repertoire 
 
The regulatory promoter, located upstream and downstream the core promoter (around -
250 to +250bp from TSS), is a region bound by several TFs, which, together with other 
TFs bound to the distal regions, interpret the genetic regulatory information and coordinate 
the RNA pol II activity (Butler and Kadonaga, 2002).  
Activators are proteins that interact with regulatory promoters increasing the rapidity of 
PIC formation or, generally, by promoting the elongation and the reinitiation. The activator 
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functions are modulated by coactivators, group of factors recruited throughout protein-
protein interaction, which regulate positively or negatively activators and modify the 
chromatin (Maston et al., 2006).  Among the coregulators, there are enzymes involved in 
histone tail modifications, such as the histone acetyltransferases p300/CREB-binding 
protein (CBP), which seem to be necessary for the opening of chromatin and consequently 
for PIC recruitment (Magnani et al., 2011).  
Enhancers can be localized several hundred kilobase pairs upstream or downstream of a 
promoter, inside an intron or even beyond the 3’ end of the gene eliciting their functions in 
distance and orientation independent manner respect to the promoter (Maston et al., 2006; 
Bulger and Groudine, 2011). Enhancers, like regulatory promoters, contain several TFs 
binding sites, which allow the simultaneous binding of TFs that, in turn, leads to the 
recruitment of coactivators and generate a cell type specific proteins complex. This higher 
order multicomponent complex is responsible for the RNA pol II recruitment and for the 
modification of the histone tails in nucleosomes (Panne, 2008).  
Depending on the type of modification harbored by enhancer-associated nucleosome, it is 
possible to classify enhancers as constitutive, poised, latent or repressed (Fig. 3). For 
example in macrophages all classes are characterized by both H3K4 monomethylation 
(H3K4me1) and PU.1 binding, the macrophages master regulator, except for the latent 
enhancers that, prior stimulation, lack histone marks and are unbound by TFs. However, 
after lipopolysaccharide (LPS) stimulation, latent enhancers display H3K4me1, H3K27ac 
and PU.1 binding (Ostuni et al., 2013). Constitutively and repressed enhancers are 
additionally characterized by the presence of H3K27 acetylation (H3K27ac). The 
difference between these two classes resides in their behavior after LPS stimulation, 
H3K27ac in constitutive enhancers can increase (constitutive activated) or can be 
unaffected (constitutive non-activated), whereas in repressed enhancer can be lost or 
strongly reduced. Regarding poised enhancers, they are marked by H3K4me1 and PU.1 
binding and are devoid of H3K27ac, thus they are primed but not active and require the 
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presence of additional signals to be fully activated. Nevertheless, after stimulation the 
majority of them are unaffected (poised not-activated) whereas, a small subset can be 
marked by H3K27ac (poised activated) (Ostuni et al., 2013). Furthermore, poised 
enhancers can be associated also with the chromatin repressive mark (H3K27me3) (Heinz 
et al., 2015). One of the most interesting enhancers features is cell type specificity. 
Studying the chromatin landscape, it has been noted that each cell type utilizes only a 
small fraction of all possible enhancers. It has been estimated that the total number of 
enhancers is around 1 million but the combinatorial activity of lineage determining TFs 
(LDTFs) selects 20000-40000 cell-type specific enhancers (Bulger and Groudine, 2011; 
Glass and Natoli, 2016). Therefore, each cell type has its own repertoire of cis-regulatory 
regions, which is critical for determining the cell's identity and the ability to respond to 
internal and external signals. 
 
Figure 3. Classification of macrophages enhancers.  
Classification of macrophage enhancers based on histone modification and PU.1 recruitment in unstimulated 
or LPS-stimulated macrophages. Adapted from (Ostuni et al., 2013). 
 
This implicates that enhancers can shape the signal-depended gene expressions (Ghisletti 
et al., 2010; Heinz et al., 2015). Each cell type responds in a different way to an identical 
stimulus because the broadly expressed TFs, activated by the stimulus, bind the unique 
repertoire of enhancers resulting in a transcriptional response that is cell type specific 
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(Heinz et al., 2015). This occurs with two different mechanisms that can arise at the same 
time in the same cell type. In one case signal-dependent TFs (SDTFs) bind enhancers 
already selected by the LDTFs, therefore in absence of LDTFs, SDTFs is not able to 
recognize and to bind the regulatory regions. Otherwise, SDTFs can cooperate with 
LDTFs in the unveiling of latent enhancers (Fig. 4) (Kaikkonen et al., 2013; Ostuni et al., 
2013).  It seems that enhancers act as platform that receives information from multiple 
signalling cascades and than generates response acting on certain promoters (Maston et al., 
2006). In the past, different mechanisms of enhancer action have been proposed: a 
“looping” model, the most reliable, and an alternative or “oozing” model. In the looping 
model enhancers and promoters interact through the DNA bending while in the alternative 
model a complex, that recognizes enhancers, flows through the DNA to research the 
promoter (Bulger and Groudine, 2011). 
 
 
 
Figure 4. Cell type-specific enhancers’ selection and activation.  
(a) Enhancers’ selection followed by the interaction of LDTFs and collaborating transcription factors (CTFs) 
during differentiation and enhancers activation accomplished by SDTFs. (b) Latent enhancers’ selection 
mediated by the cooperation between LDTFs and SDTFs. (Heinz et al., 2015) 
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The chromosome conformation capture, and their high-throughput derivates, confirms the 
existence of the looping model in which the looping structure is stabilized by the 
transcription factors loaded both on promoters and enhancers and it is associated with 
paused RNA pol II prior to gene activation (Ghavi-Helm et al., 2014). 
Chromosome conformation approaches detected correlation between enhancers and 
promoters, on average active promoters are associated with 4-5 distal elements and, vice 
versa, enhancers are found to contact approximately two promoters (van Arensbergen et 
al., 2014).  
As anticipated before, the diversity in core promoter elements and therefore the 
recruitment of different components of the transcriptional machinery influences the 
interaction between enhancers and promoters. Zabidi et al. reported that in Drosophila 
enhancers can exhibit specificity for TATA versus DPE core promoter motif, resulting in 
distinct transcriptional properties, namely regulating tissue-specific or developmentally 
regulated genes (Zabidi et al., 2015). Therefore, the core promoter is not merely a platform 
on which the transcription machinery assembles. Rather, it has been proposed the 
existence of two subsets of enhancers that interact specifically with core promoter of 
housekeeping genes or developmental genes, suggesting the core promoter involvement in 
gene regulation. It has been proposed that this interaction could be due to biochemical 
compatibilities of proteins assembled both on promoters and enhancers (Zabidi et al., 
2015) and to the chromatin architecture, such as the presence of topological associated 
domains (TADs) and the presence of insulator elements (van Arensbergen et al., 2014). 
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2.2.2 Transcription Factors recruitment 
 
The commitment of regulatory regions in a cell-type depends on the chromatin status that 
can act as a barrier for most TFs. The TF recruitment relies on the presence of pioneer TFs 
and on the chromatin context such as the nucleosome position, the epigenetic 
modifications and the three dimensional chromatin organization. All these elements 
control the TFs binding in spatial and temporal manner. 
Generally promoters, regardless for the cell types, are nucleosome free regions and thus 
the transcription factor binding is not prevented. On the contrary, the enhancer 
accessibility is highly variable and depends on the cell-type, for this reason only in certain 
cells a specific enhancer can be bound by TFs (Magnani et al., 2011).  
TFs recognize a sequence of 6-12 bp, however, the binding specificity is dictated by only 
4-6 nucleotides. Since TFs can bind DNA as homo- or heterodimers and the binding site of 
a single TF can occur in different orientation and spacing relative to other TFBS, the 
cooperative binding between different TFs increase the variability of DNA motifs that are 
recognized by single TFs. Recently, with the CAP-SELEX technique it has been 
discovered that TFs have different specificity for the sequence recognized when they act 
alone or together with other TFs. The cooperative binding decreases the stringency of the 
specificity meaning that proteins belonging to the same family (for example class I, II and 
III ETS proteins), which recognized different 5’ flank sequences, could bind to the same 
DNA motifs thanks to the presence of the other partner (TEAD4) which mask the 
difference in binding specificity (Jolma et al., 2015). 
Therefore, the cooperative binding between different TFs increases the number of 
regulatory regions that can be bound and, depending on which TFs is expressed in spatial 
and temporal manner, it is possible to control gene expression in different cell types 
(Rodda et al., 2005; Panne et al., 2007; De Val et al., 2008). However, as it is inferred by 
the existence of many potential target sites which are not bound by TFs, the merely 
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presence of the binding site is not a sufficient requisite for the TF binding. For instance, 
PU.1 can potentially bind, with different stringency, between 650000 and 1,4 milion site 
(Heinz et al., 2013; Barozzi et al., 2014), however, PU.1 ChIP-seq experiment showed that 
only around 45000 sites are bound in macrophages (Heinz et al., 2010).  In addition to the 
nucleotide sequence and the cooperative DNA-binding of TFs, other features influence the 
TFs binding such as nucleosome occupancy and the DNA methylation (Slattery et al., 
2014).  
Several studies unveiled the existence of a dynamic equilibrium where sequences switch to 
be bound by nucleosomes or by TFs revealing that nucleosomes and TFs compete for the 
same DNA sequences (Mirny, 2010). According to this model, Segal group found out that 
p53 binds preferentially regions with high intrinsic nucleosome occupancy score (INOS); 
in the absence of p53 these regions are occupied by nucleosome but after p53 activation 
the nucleosome occupancy is reduced (Lidor Nili et al., 2010). Additionally He et al. 
reported that two TFs, which bind to DNA independently, are able to evict nucleosome if 
their binding site is within 150 bps from each other (He et al., 2013). 
Barozzi et al., demonstrated that TFs recruitment and nucleosome depositions are 
controlled by overlapping DNA sequence and shape features. In macrophages, and in other 
PU.1 expressing cells, PU.1 binding occurs on sites that in PU.1-not expressing cells are 
occupied by nucleosomes. In contrast, PU.1 consensus sites that are not bound by PU.1 are 
devoid of nucleosomes. Accordingly to these results, PU.1 expression in PU.1-lacking 
cells is sufficient to generate nucleosome free regions (Ghisletti et al., 2010). Therefore, 
considering the CG content, the 3D shape and the binding of other TFs it is possible to 
predict at genome scale both PU.1 binding and nucleosome deposition (Barozzi et al., 
2014). Distal and TSS-proximal regulatory elements bound by Pu.1 show different 
nucleosome occupancy due to the differences in their sequences. The abundance of 
cytosine and guanosine dinucleotide positively impacts on the nucleosome assembly, until 
a specific point beyond which the extremely high C-G content is not compatible with 
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efficient DNA bending around histones and thus it impedes the nucleosome deposition  
(Glass and Natoli 2016). This hints that the nucleosome depletion at TSS- proximal 
regions is not dependent on Pu.1 binding but rather on the high G+C content which 
interferes with nucleosome assembly (Barozzi et al., 2014). All these results suggest that 
the cell type-specific transcription depends on the interplay between nucleosomes and TFs 
binding.  
As anticipated before, DNA methylation is an epigenetic modification that interferes with 
TFs binding. Indeed, this modification, as already mentioned, has been considered one of 
the causes of gene silencing which is accomplished through the recruitment of repressor 
proteins and the alteration of TFs accessibility to their recognition site (Nan et al., 1998). 
Generally, the variation in TFs recruitment concerns proteins that contain the CG di-
nucleotide on their cognate site. For instance ETS, NF-kB, AP-2 and Myc proteins belong 
to the group of methylation-sensitive proteins since their binding is impaired after DNA 
methylation. However, it exists also methylation-insensitive proteins, such as Sp1, CTF 
and YY1, which are recruited despite the presence of methyl group in their cognate site. 
The existence of methylation-sensitive and insensitive proteins suggests that the lack of 
recruitment of the methyl-sensitive proteins does not depend on the mask of the binding 
site mediated by the methyl group but rather should rely on other mechanisms which 
selectively repress some genes and not others. This is further confirmed by recent evidence 
regarding the CTCF binding and the DNA methylation, which suggests that CTCF 
occupancy is impeded by the methyl group only on a subset of sites (Maurano et al., 2015).   
However, the mechanism by which proteins recognize their functional binding sites has 
not been completely understood and recent findings speculate that the TFs can interpret 
both the base and shape readout (Slattery et al., 2014).  
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2.3 ETS proteins 
 
The ETS proteins are one of the largest families of winged helix-loop-helix DNA binding 
proteins that consist of approximately 30 members expressed in many different cell types. 
They are downstream effectors of many pathways and they control various cellular 
functions throughout development and adulthood. They have been reported to be involved 
in cellular proliferation, differentiation, hematopoiesis, apoptosis, metastasis, tissue 
remodeling, angiogenesis and transformation (Charlot et al., 2010).  
The common feature of ETS proteins is the 85 amino acids, highly conserved DNA-
binding domain, namely the ETS domain, which recognizes a conserved core GGAA/T 
motif. The binding specificity of each ETS protein depends on the nucleotides flanking the 
conserved bases (Gallant and Gilkeson, 2006). 
Some ETS proteins have a reduced binding affinity due to the presence of two inhibitory 
regions, the inhibitory module and the serine rich region, that flank the DNA binding 
domain (Hollenhorst et al., 2011).  
Genome-wide analysis showed both specific and redundant ETS proteins occupancy. 
Indeed different ETS factors can bind identical site, generally located on the proximal 
promoter of the housekeeping genes, in different cell-types suggesting a functional 
redundancy of some ETS proteins. Instead, specific binding sites are low affinity sites 
flanked by recognition sites for other TFs that in turn stabilize the ETS binding. ChIP-seq 
studies performed in human T-cell lines showed that ETS1, ELF1 and GABPa have more 
frequently redundant, than specific binding that is characterized by degenerate site located 
far from TSS of cell-specific genes (Hollenhorst et al., 2007). It is thought that redundancy 
could be a strategy to guarantee stable expression of housekeeping gene, independently on 
the expression level or the identity of ETS factors in different cell lines.  
One intriguing question about the ETS family, regards the binding specificity. Even if 
around half of the ETS proteins are expressed in any cell types and display highly 
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conserved DNA binding, each ETS protein can accomplish different functions. It is 
thought that additional domains that flank the ETS domain, post-translational modification 
and the interaction with other proteins can confer the tissue specific role of ETS proteins 
(Hollenhorst et al., 2007). 
High-throughput micro-well based DNA binding assay and protein-binding microarrays 
showed that the ETS-binding profiles cluster into four distinct classes (I, II, III and IV) and 
identified amino-acid residues that guarantee binding specificity (Wei et al., 2010).  
In the high-throughput micro-well TF DNA-binding specificity assay the DNA binding 
domain of each ETS protein was cloned as fusion protein together with Renilla luciferase 
gene. Subsequently, the fusion protein was incubated with biotinylated oligonucleotide 
containing sequence with high affinity to all known ETS factors in the presence of non-
biotinylated double-stranded competitor oligonucleotides containing every possible single 
base substitution to the consensus binding site. The biotinylated oligonucleotides were 
then captured on a streptavidin plate and are incubated with luciferase substrate. Reduction 
in luciferase activity revealed that the non-biotinylated sequences have a higher affinity for 
the TF-Renilla fusion protein compare to the biotinylated oligonucleotide (Hallikas and 
Taipale, 2006; Wei et al., 2010). 
Whereas in the protein binding microarray, the binding specificity was measured on a 
microarray that contains all possible DNA sequence variants of a 10-mers sequence. 
Precisely, 44000 single-stranded features were attached to a microarray slide, each feature 
contains 26 distinct overlapping 10-mers. The binding specificity was measured acquiring 
the fluorescence intensity of the studied protein expressed with a glutathione S-transferase 
epitope tag (Berger et al., 2006). 
Class I, the largest group, contains 15 members and includes ERG, ETV1, ETV4 and 
FLI1, the cancer-associated ETS factors. The other classes (II, III and IV) include 8, 3 and 
1 member(s). The class II is further subdivided into two, IIa and IIb based on the binding 
specificity. This classification is due to the different set of amino acid residues which form 
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the DNA binding domain and, therefore, which interact with the nucleic acids. 
A substitution of a single amino acid is sufficient to shift a factor from a class to another. 
For example, if a leucine of ELF4-DBD is mutated with phenylalanine or tyrosine, ELF4 
can be considered a member of class I (Wei et al., 2010). The ETS proteins binding mode 
can be cooperative or not, as they can bind their respective site alone or within a ternary 
complex (Gallant and Gilkeson, 2006). The ETS proteins regulate, both in positive and in 
negative manner, the transcription through DNA binding. Several ETS factors can act 
either as activators and repressor depending on the type of promoter and they can be 
regulated by the interaction with other factors or by post-translational modifications that 
control their subcellular localization, DNA-binding activity or stability (Charlot et al., 
2010). Loss-of-function studies showed that ETS proteins have specific functions in 
development. For example TFs that belong to class I, IIb and III are involved in different 
stages of hematopoiesis (which in part reflects their different expression patterns) (Wei et 
al., 2010).  
Below it is reported a brief overview on the role of some ETS factors. 
 
2.3.1 GABP  
 
GABP (GA binding protein) has the peculiarity of being the only tetrameric factor, it is 
composed by two dimers of two subunits (α and β), the α subunit contains the DNA 
binding domain and the OST domain, which is implicated in co-factors recruitment, 
whereas the β subunit contains the transcriptional activation domain, the nuclear 
localization signal and it confers stability to the protein-DNA interaction (Rosmarin et al., 
2004). The oxidation of cysteine residues contained in the dimerization domains and in the 
DNA binding domain of GABP α is critical for its transcriptional activity (Wu et al., 
2013). 
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Figure 5. Structural organizations and binding specificities of mammalian ETS TFs. (Left) Schematic 
representation of the domain structures of the respective full-length proteins. ETS domain is in blue, pointed 
domain is in green, Proline-rich domain is in grey. The second column shows mouse ETS-binding profiles. 
Adapted from (Wei et al., 2010). 
 
Regulating the expression of genes necessary for cell adhesion, clearance of pathogens and 
genes involved in the inflammatory response, GABP seems to be necessary for 
development and function of myeloid cells. GABP is also a transcriptional regulator of 
several cytokines and cytokine receptors involved in the growth and function of 
hematopoietic cells such as IL-2 and IL-4. Additionally, GABP is a key regulator of 
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essential housekeeping genes as suggest by its involvement in the regulation of ribosomal 
and mitochondrial genes and by its role in cell growth and antioxidant defense. Recently, it 
has been discovered that the GABP regulates the expression of Yap protein, which is 
critical for cell survival and cell-cycle progression (Rosmarin et al., 2004; Wu et al., 2013) 
Therefore, GABP is a key regulator of both lineage restricted and housekeeping genes and 
GABP α knock out mice show early embryonic lethality confirming GABP requirement 
for fundamental cellular process such as cellular differentiation, maturation and activation 
(Wu et al., 2013). Despite its role in regulating housekeeping genes, GABP is not 
ubiquitously expressed but it is abundant in hematopoietic cells, specifically myeloid cells 
and in a wide variety of cell types such as liver, muscle, testis and brain. Instead, the 
lineage-restricted gene regulation seems to be mediated by the interaction with other TFs, 
such as Sp1 and PU.1, and with co-factors such as p300 (Rosmarin et al., 2004). 
 
2.3.2 FLI 1  
 
FLI1 (Friend leukemia insertion 1) is initially identified as an oncogene, it controls 
vasculogenesis, cell cycle, apoptosis and has several roles in embryonic development.  
It is expressed primarily in both endothelial and hematopoietic cells regulating the 
development of hematopoietic stem cells, megakaryocytes, myelomonocytes, erythrocytes 
and NK cells. FLI1 regulates the expression of vascular homeostasis genes and of several 
megakaryocyte-specific genes. FLI1 knockout mice, as GABP knockout mice, show 
embryonic lethality, they are characterized by absence of megakaryocytes and aberrant 
vasculogenesis, which implies FLI1 involvement in embryonic development (Hart et al, 
2000). Aberrant expression of FLI1 is detected in hematopoietic and epithelial tumors and, 
in humans, the chromosomal translocation of the FLI1 DNA binding domain to the EWS 
locus on chromosome 22 leads to Ewings sarcoma. Depending on the context, Fli1 may act 
both as oncogene or tumor suppressor. In hematopoietic tumors, such as erythroleukemia, 
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FLI1 is highly expressed and it acts as oncogene regulating genes involved in proliferation, 
survival and differentiation. Related to this, human breast cancers are characterized by 
reduced level of FLI1 mRNA, the loss of FLI1 correlates with accelerate tumor growth and 
increase in the expression of proteins associated with cancer progression (i.e. Ki67) and in 
the number of lung metastases (Scheiber et al., 2014). 
FLI1 is also involved in autoimmune disease and, likewise in tumor, both its 
overexpression and down-regulation can lead to diseases: transgenic mice overexpressing 
FLI1 show systemic lupus erythematosus-like sintoms, on the contrary the downregulation 
of FLI1 seems to increase the pathogenicity of the Systemic sclerosis or scleroderma ,  
 
2.3.3 ELF1  
 
ELF1 (ETS like factor 1) exists in two-forms: 98 kDa in the nucleus and 80 kDa in the 
cytoplasm (Juang et al., 2002). This difference depends on post-translational modifications 
since ELF1 can be phosphorylated and glycosylated at the same time. These modifications 
are responsible for subcellular localization, protein-protein interactions and protein-DNA 
interactions. ELF1 is bound to retinoblastoma protein in the cytoplasm while, in the 
nucleus it interacts with target promoters (Charlot et al., 2010). ELF1 is highly expressed 
in a variety of endothelial cells, in both embryonic and adult lymphoid tissues and during 
thymocyte development its level remains similar in all subset of maturing thymocytes and 
T cells. Interestingly, ELF1 is present at high levels also in the epithelial cells of oral 
mucosa, in the central nervous system, in the lung, in the gastrointestinal tract, in urinary 
tracts and in the skin. Liver and testis of adult mouse present lower levels of ELF1 (Bassuk 
et al., 1998). Like most of the ETS factors, it is implicated in hematopoiesis, angiogenesis 
and in the development of NK and NKT cells (Choi et al., 2011). It activates the 
expression of many T cell genes such as the TCR chain while in B cells it cooperates with 
members of the AP1 family to activate the 3’ IgH enhancer in response to stimulation with 
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IgM (probably it is involved in class-switch recombination) (Gallant and Gilkeson, 2006). 
ELF1 also allows the expression of the granulocyte-macrophage colony stimulating factor 
(GM-CSF) gene, the interleukin-2 receptor alpha subunit gene and the CD4 gene. ELF1 
binding sites have been identified in the transcriptional regulatory elements of multiple 
genes involved in T cell, B cell and macrophage development and activation (Bassuk et al., 
1998). Additionally, ELF1 seems to be a potential key regulator of expression of key 
hematopoietic genes, including Scl, Fli1, Lyl1, Runx1, Lmo2 and PU.1; it is interesting to 
note that for the last gene the activation is reciprocal, as PU.1 is a major regulator of ELF1. 
ELF1 downregulation is indispensable for the erythroid differentiation (Calero-Nieto et al., 
2010).  
 
2.3.4 ELF4  
 
ELF4 (E74 Like ETS Transcription Factor 4) is an ETS factor closely related to ELF1. It is 
involved in cell cycle regulation and, together with ELF1, it is implicated in NK and NKT 
cell development. Studies showed its involvement, acting at promoter level, in the 
expression of IL-8, a chemotactic factor for neutrophils, basophils, eosinophils and, 
probably, for lymphocytes. It has also a tumor-suppressor role (Gallant and Gilkeson, 
2006). This latter function is carried out through the activation of the tumor suppressor 
KLF4, which induces cell-cycle arrest in naïve CD8+ T cells. Therefore, ELF4 is a 
negative regulator of proliferation of naive CD8+ T cells, which do not respond to weak 
self-MHC signals. With regards to the role in NK cells, ELF4 prepares them to a rapid 
response after stimulation, activating perforin gene expression. Finally ELF4 is also 
involved in proliferation of B cells, ovarian epithelial cancer cell lines and HSCs 
(hematopoietic stem cells) (Yamada et al., 2009).  
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ELF2, ELF3 and ELF5 are other ELF1 paralogues; ELF2 is expressed at low levels in 
macrophages, whereas ELF3 expression is transiently induced by pro-inflammatory 
cytokines. Instead, ELF5 is not expressed in macrophages (Grall et al., 2003).  
Even if ELF1 and ELF4 seem closely related, knockout experiments display different roles 
for the two proteins. While ELF1 is implicated only in the development and function of 
NKT cells (ELF1-/- mice produce less amount of cytokines upon antigene stimulation) 
(Choi et al., 2011), ELF4 knockout mice present defect both in NK and NK-T cell 
differentiation, resulting in a decreased amount of the two cell-types respect the WT mice. 
Conversely from what occurs in ELF1 null mice, the lack of ELF4 does not impair the 
cytokines secretion from NK-T cells whereas it impairs the secretion of IFNγ and the 
expression of perforin gene in NK cells (Lacorazza et al., 2002).  
 
2.3.5 PU.1 
 
PU.1 (Purine-rich box 1) is characterized by three domains: the trans-activating, the PEST 
and the DNA-binding domain. The former contains a proline-rich region that allows 
intramolecular bonds and interaction with other proteins. The second, called PEST for the 
presence of proline-, glutamic acid-, serine- and threonine-rich regions, is a target for 
peptidases allowing the rapid turnover of PU.1. This domain is also necessary for the 
conformational changes and the interaction with other proteins due to the presence of 
several serine-phosphorylation sites. The phosphorylation of serine 148 is required for the 
interaction of PU.1 with other proteins in B cells. This modification is also necessary for 
PU.1 roles in macrophages proliferation (phosphorylation of serines 41 and 45), as 
suggested by mutagenesis experiments (Celada et al., 1996). Finally, the DNA binding 
domain recognizes the sequence 5’-AG(A/C/G)GGAAG-3’ (PU box). PU.1 is expressed at 
really high levels during early stages of hematopoietic development. The amount of PU.1 
is critical to establish progenitor differentiation into B cells (low level of PU.1) or 
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monocytes (high level) (Gallant and Gilkeson, 2006). For normal development of 
megakaryocites, erythroid progenitors, B and T cell progenitors PU.1 levels are low, 
whereas to induce and then maintain macrophage differentiation PU.1 must be constantly 
expressed at high levels (Rosenbauer et al., 2006; Kueh et al., 2013). PU.1 deficient mice 
die of severe septicemia 48h after birth since they have a defective development of 
macrophages, T and B cells. Neutrophils also require the presence of PU.1 for the 
secondary granule components expression since PU.1 deficiency affects the ability to 
ingest and kill bacteria (Gallant and Gilkeson, 2006). 
 
2.3.5.1 PU.1: the master myeloid regulator 
 
Macrophages originate from circulating peripheral-blood mononuclear cells (PBMCs) that 
are released from bone marrow to blood where they circulate for several days before 
entering into the tissues and replenishing the tissue macrophage populations. The 
differentiation of lymphoid and myeloid lineages from the common precursor relies on the 
enhancers’ selection (Romanoski et al., 2015). As already mentioned, the combinatorial 
activity of LDTFs, which are able to bind compacted chromatin, controls the enhancers’ 
selection, namely they convert inactive enhancers in to primed, poised or active (Natoli, 
2010; Calo and Wysocka, 2013). PU.1 binds different regulatory regions in macrophages 
and in B cells interacting with LDTFs specific for the two cell lineages. In macrophages 
the cis-regulatory repertoire is defined by the interplay of PU.1 with CCAAT/enhancer-
binding proteins (C/EBPs) and AP1, whereas in B cells PU.1 binding occurs in proximity 
(<100 bp) to the EBF1, E2A and OCT binding sites (Heinz et al., 2010). These 
dissimilarities in the enhancer repertoire justify also the capability of different cell types to 
respond in distinct way to an identical stimulus. Indeed, LPS activates, in both 
macrophages and B-cells, NF-kB, a broadly expressed SDTF, nevertheless, due to the cell-
type-specific enhancers, NF-kB activation results in a different pattern of gene expression 
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(Glass and Natoli 2016).  
The enhancer’s selection, mainly mediated by PU.1, depends on the role of both internal 
and external signals and can explain the heterogeneity of macrophage populations 
(Romanoski et al., 2015). The Langerhans cells that populate the epidermis, osteoclasts, 
alveolar macrophages, microglia in the central nervous system, metallophilic macrophages 
that sample the circulation with unknown function, and the Kupffer cells in the liver are 
just some examples of macrophage populations which differs for their enhancer’s 
repertoire (Gordon and Taylor, 2005). Therefore, the ability of macrophages to 
differentiate themselves in each tissue is due to the environmental inputs received from the 
surrounding cells and to the intrinsic differentiation pathways (Lawrence and Natoli, 
2011). In different macrophage subtypes, as already seen for different cell types, PU.1 
primes a series of potential enhancers but, depending on the stimuli received, only a part of 
them can be activated and consequently can trigger a gene program that is specific for each 
tissue (Fig. 6). For example, PU.1 primes a set of enhancers that can respond to retinoic 
acid or TGFβ and that, consequently, become active only in milieu such as peritoneal 
cavity or brain in which these two stimuli are respectively present (Romanoski et al., 
2015). Additionally, two recent works revealed the role of environment in shaping the cis-
regulatory regions independently of cell origin (Lavin et al., 2014; Romanoski et al., 
2015). The macrophage plasticity does not reflect only their capability to differentiate in 
different phenotypes depending on the stimulus, but it also embraces the possibility of 
inter-conversion between different macrophage subtypes when cells are exposed to a new 
microenvironment. Similarly, tissue-specific macrophages, when transplanted to a 
different anatomic location, are subjected to the reprograming of the gene expression 
(Romanoski et al., 2015). This suggests that macrophage differentiation is not an 
irreversible process; conversely microenvironment is able to shape and to reprogram the 
chromatin landscape (Lavin et al., 2014). PU.1 might act as a pioneer factor since it 
promotes the deposition of H3K4me1 and generates open regions of DNA accessible for 
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other TFs. Indeed, ChIP-seq analysis revealed that the genomic distribution of PU.1 is 
widespread in macrophages and it correlates with almost all genomic enhancers marked by 
H3K4me1 (Ghisletti et al., 2010). Pioneer factors are able to bind DNA when other factors 
cannot, such as in the presence of condensed chromatin. They can open chromatin, modify 
nucleosomes position, enable intrinsic cooperative binding and recruit chromatin modifiers 
and co-regulators (Zaret and Carroll, 2011).   
 
Figure 6. Schematic representation of enhancers’ selection upon environmental signal. 
Primed enhancers are activated following environmental signal leading to the expression of environment-
induced genes, which include also collaborative TFs. Subsequently, tissue-specific enhancers are unveiled by 
the interaction between collaborative TFs and LDTFs. The combined activity of direct and indirect targets 
allows determining the identity of macrophages in a particular environment (Link et al., 2015). 
 
Thus, since PU.1 is able to reprogram the chromatin landscape through epigenetic 
modifications and maintain enhancers in an open chromatin conformation, it can be 
considered a pioneer factor even if the biochemical evidences are still lacking (Magnani et 
al., 2011). However, studies unveiled that the cooperative binding between PU.1 and other 
TFs is required to open chromatin of certain regions. As inferred by ChIP-seq experiments 
performed in macrophages, the Interferon regulatory factor-8 (IRF8) is another known 
partner of PU.1, besides C/EBP and AP-1 family members. All together these factors 
control myeloid-cell development (Ghisletti et al., 2010). PU.1 and C/EBP binding, 
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occurring at the same distal regions, is frequently reciprocally dependent. Mutagenesis 
experiments, in which the C/EBP recognition motif carries mutation that abolish the 
C/EBP binding, demonstrated that PU.1 binding to its nearby intact cognate site is affected 
by the absence of C/EBP. Likewise mutation in the PU.1 binding motif causes impairment 
both of PU.1 binding and of C/EBP binding to its intact binding site (Heinz et al., 2013). 
Additionally it has been suggested that in immune cells, a subset of IFN-stimulated 
response element (ISREs) called the ETS/IRF response element, is activated by IRF-8 in 
cooperation with PU.1 (Tamura et al., 2005). Indeed cooperative interaction between IRF8 
and PU.1 in basal condition is required for the expression of a subset of genes crucial for 
macrophage activity (Mancino et al., 2015). This suggests that the cooperative interaction 
between two TFs is required to compete with histones. Therefore, it is likely that PU.1, 
C/EBP and other macrophage LDTFs act to define the specific repertoire of enhancers 
(Heinz et al., 2013). However, in the majority of cases, PU.1 alone is able to bind DNA 
and to allow the binding of other proteins, which are not able to contact DNA 
independently (Gallant and Gilkeson, 2006). Therefore, PU.1 is the myeloid master 
regulator that establishes and maintains the chromatin landscape of macrophages. 
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3. Aim 
 
Cis-regulatory elements (promoters and enhancers) capable of initiating transcription 
contain both motifs recognized by sequence-specific TFs, which collaboratively recruit the 
RNA Pol II initiation complex, and core promoters, namely DNA sequences that enable 
initiation of RNA synthesis (Kadonaga, 2012).Transcriptionally competent cis-regulatory 
elements differ not only because of the TF binding motifs they contain, but also in core 
promoter composition and architecture. Such diversity probably reflects the specific and 
unique regulatory requirements of each individual gene (Tong et al., 2016) and is 
consistent with the observation that core promoter elements, in addition to enable 
initiation, also contribute to gene regulation (Zabidi et al., 2015).  
However, the identity of factors able to bind to these regions and thus to regulate gene 
expression remains to be entirely determined. Specifically, the basic mechanism by which 
the core promoter of constitutive active genes, lacking strong core promoter elements and 
characterized by multiple weak start sites, are able to maintain a steady level of 
transcription is not well understood. 
We set out to mechanistically dissect those cis-regulatory elements that in terminally 
differentiated cells are endowed with constitutive transcriptional activity. We used a well 
characterized system, primary mouse macrophages, in which the class III ETS family 
member Sfpi1/PU.1 determines H3K4me1 deposition and nucleosome depletion at the vast 
majority of macrophage-specific enhancers as well as at a fraction of the promoters of 
macrophage-specific genes (Barozzi et al., 2014; Ghisletti et al., 2010; Heinz et al., 2010; 
Ostuni et al., 2013). 
We found out that class I and II ETS sites, but not PU.1 site, were overrepresented on 
TSS-proximal regions of constitutively expressed genes. For its relative position to TSS, 
the ETS site could be a good candidate as a possible genomic element involved in 
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promoting transcription. Therefore, this prompted us to deeply investigate the specific role 
(if any) of ETS proteins in transcriptional activity. 
Genomic distributions of ETS family members expressed in macrophages indicated that 
some ETS proteins (GAPBA, ELF1 and ELF4) but not others (FLI1 and PU.1) had a 
striking binding preference for TSS-adjacent regions.  
Interestingly, the ability of ETS proteins to bind to core promoters was not simply related 
to DNA binding preferences, but instead was related to the ability to recruit the general 
transcription machinery. By using functional, genetic and proteomic approaches we 
determined a crucial role of ELF proteins in controlling the constitutive transcriptional 
activity of a broad panel of distal and gene-proximal cis-regulatory elements. Overall, 
these data indicate that a distinct subset of ETS proteins imparts high transcriptional 
activity to a broad range of both housekeeping and tissue-specific cis-regulatory elements. 
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4. Materials and methods  
4.1 Cell growth and treatment conditions  
Macrophages were derived from bone marrows of C57/BL6 mice (Harlan) and plated in 10 
cm dishes for 6 days in 10 ml of BM-medium (Dulbecco's Modified Eagle's Medium 
(DMEM) supplemented with 20% low-endotoxin fetal bovine serum (FBS), 30% L929 
conditioned medium, 1% glutamine, 1% penicillin-streptomicin, 0.5% sodium pyruvate 
and 0.1% β- mercaptoethanol). RAW 264.7 (mouse macrophages), Hepa 1-6 (mouse 
hepatoma cells) and L-Wnt-3A (mouse fibroblasts) were purchased from the American 
Type Culture Collection (ATCC). RAW 264.7 and Hepa 1-6 cells were grown in DMEM 
supplemented with FBS (North and South America origin respectively), 1% penicillin-
streptomicin and 1% glutamine, whereas L-Wnt-3A cells were grown in DMEM 
supplemented with FBS (South America origin), 1% penicillin-streptomicin, 1% glutamine 
and 400 µg/ml G418. 
Stimulations were carried out at day 6 with LPS from E.Coli serotype EH100 (Alexis) at 
100ng/ml and with a-amanitin (Sigma) at 10ng/ml.  
 
4.2 Chromatin Immuno Precipitation coupled with sequencing  
Macrophages (8 x 107 for FLI1 and ELF1, 4 x 107 for GABPA and ELF4 or 5 x 106 for 
PU.1) and RAW264.7 cells (8 x 107  for RNA Pol II and 2 x 107   for H3K27ac) were fixed 
for 10 minutes with 1% of formaldehyde and were lysed in RIPA buffer (140 mM NaCl, 
10mM Tris-HCl pH 8.0, 1mM EDTA pH 8.0, 1% Triton x-100, 0,1% SDS, 0,1% DOC). 
After chromatin shearing by sonication, lysates were incubated with 10 µg of the following 
antibodies: ELF1 (Santa Cruz sc-631x), ELF4 (homemade), FLI1 (Santa Cruz sc-356x), 
GABPA (Santa Cruz sc-22810), RNA Pol II (Santa Cruz sc-889x) and 3 µg of PU.1 
antibody (home made) and H3K27ac (Abcam ab4729). Antibodies were prebound 
overnight to 75 µl of G protein-coupled para-magnetic beads (Dynabeads) in PBS/BSA 
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0.5%. Beads were then added to lysates (the preclearing step was omitted), and incubation 
was allowed to proceed overnight. Beads were washed six times in a modified RIPA buffer 
(50 mM HEPES (pH 7.6), 500 mM LiCl, 1 mM EDTA, 1% NP-40, and 0.7% Na-
deoxycholate) and once in TE containing 50 mM NaCl. DNA was eluted in TE containing 
2% SDS and crosslinks reversed by incubation overnight at 65°C. DNA was then purified 
by Qiaquick columns (QIAGEN) and quantified with QuBit (Thermo FIscher). For 
validation by ChIP-QPCR, purified DNA was used for amplification on an Applied 
Biosystems 7500 Fast Real-time PCR system (with Applied Biosystem Sybr-green). ChIP 
DNA was prepared for HiSeq2000 sequencing following standard protocols.  
 
  4.3 Plasmid construction  
Endogenous promoters were cloned into pGL3-basic vector (Promega) between NheI and 
KpnI sites. The genomic regions cloned, with the distance of the ETS site from the TSS, 
are shown in Table 1. All the primers used to clone the regions of interest contain two 
restriction enzyme sites and the SP1-INR sequence (5'-CCCGCCCATCTTG-3', the -1 / +1 
Py / Pu dinucleotide is underlined) (Weis and Reinberg, 1997). Primers were designed 
with sticky ends, considering the restriction enzymes cut, in order to avoid the digestion 
step. 20 µM of primers were annealed in NEB buffer 2 at 95°C for 4 minutes and then 
were slowly cooled to room temperature over the period of several hours. 2 µl of annealed 
primers were ligated into 20 ng of pGL3-basic vector using T4 ligase enzyme (NEB) at 
16°C for 4-20 hr.  
 
Name Genomic position TSS distance (pb) 
P1 chr7 12922248 12922309 40 
P2 chr3 137581390 137581490 33 
P3 chr6 83028284 83028384 38 
P4 chr15 78971617 78971717 45 
P5 chr4 116270265 116270365 24 
P6 chr19 38129430 38129530 25 
P7 chr7 74367394 74367494 42 
P8 chr2 152673600 152673700 45 
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P9 chr17 22099418 22099518 24 
P10 chr5 110425440 110425540 19 
P11 chr7 52151349 52151449 15 
P12 chr19 5041310 5041410 12 
P13 chr2 69723654 69723754 53 
P14 chr12 86621368 86621468 59 
P15 chr2 4933837 4933937 36 
P16 chr11 57985063 57985163 62 
P17 chr11 43247161 43247261 10 
P18 chr11 19018959 19019018 46 
P19 chr16 8637679 8637738 12 
P20 chr7 141447311 141447370 21 
P21 chrX 12673669 12673728 30 
P22 chrX 7841797 7841856 14 
P23 chr13 67755135 67755194 47 
P24 chr13 67269069 67269128 20 
P25 chr12 8208048 8208107 19 
P26 chr10 128821592 128821651 49 
P27 chr1 37997316 37997375 47 
P28 chr12 72085798 72085857 21 
P29 chr4 41723138 41723197 42 
P30 chr11 17211859 17211918 48 
P31 chr3 86999342 86999401 45 
P32 chr2 120404078 120404140 10 
P33 chr13 18717233 18717292 14 
P34 chr2 36049399 36049458 10 
P35 chrX 140956690 140956749 31 
P36 chr4 43023228 43023287 51 
P37 chr2 164804882 164804941 46 
P38 chr18 37644205 37644264 26 
P39 chr4 86612050 86612109 38 
P40 chr6 142345619 142345678 13 
P41 chrX 8145818 8145877 20 
P42 chr7 7121446 7121505 57 
P43 chr2 26902880 26902939 16 
P44 chr1 57995912 57995971 31 
P45 chr2 129129745 129129804 59 
P46 chr9 110656444 110656503 47 
P47 chr12 86311789 86311848 16 
P48 chr11 98026651 98026710 43 
P49 chr2 14970898 14970987 23 
P50 chr10 89732296 89732359 10 
P51 chr14 12284199 12284258 21 
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Table 1. Wild-type sequences cloned in pGL3 basic for luciferase assay.  
 
The loss-of-function mutants of the ETS site (GGAA > CCAA), ELF-to-PU.1 mutant site 
(CCCGGAAGT > AGAGGAAGT) and the enhancer regions were cloned using the same 
strategy of the wild-type primers. ETS site mutated primers are shown in Table 2, ELF-to-
PU.1 mutated primers are listed in Table 3, whereas enhancer regions are reported in Table 
4.  
  
Name Primer Sequence 
P1_F CGCGCGTGCGTCTCTACCTCTGACCCCCAAGTTTTCGCTTTGCAT
AAAAGCGCTAGTCCGCTGCCCCGCCCATCTTGG 
P1_R CTAGCCAAGATGGGCGGGGCAGCGGACTAGCGCTTTTATGCAAA
GCGAAAACTTGGGGGTCAGAGGTAGAGACGCACGCGCGGTAC 
P2_F CCGCGCGCGCAATTTCCGCCCGGGTCTCCCCCCAAGTTCCGAGT
CCCGGTACTGGAGGGTGCCCGCCCATCTTGG 
P2_R CTAGCCAAGATGGGCGGGCACCCTCCAGTACCGGGACTCGGAAC
TTGGGGGGAGACCCGGGCGGAAATTGCGCGCGCGGGTAC 
P3_F CAGTCCCGCCCCGCAGGCGGTACCCCAAGTGGCGGGCTGGGAT
CAGCCTTTAAGATGGCGTCCCGCCCATCTTGG 
P3_R CTAGCCAAGATGGGCGGGACGCCATCTTAAAGGCTGATCCCAGC
CCGCCACTTGGGGTACCGCCTGCGGGGCGGGACTGGTAC 
P4_F CGGTCGGCCGCTGCTTCCCCCAAGTAACTGCGCCTGGGTCACGG
CGCAAGCGCAAACTACGCCCGCCCATCTTGG 
P4_R CTAGCCAAGATGGGCGGGCGTAGTTTGCGCTTGCGCCGTGACCC
AGGCGCAGTTACTTGGGGGAAGCAGCGGCCGACCGGTAC 
P5_F CGGCAGTGGAATTCTGTTACCTGCCCCTGCGGTTCAACCCCCAA
ACGCTGGCTGCAGAGATCCCGCCCATCTTGG 
P5_R CTAGCCAAGATGGGCGGGATCTCTGCAGCCAGCGTTTGGGGGTT
GAACCGCAGGGGCAGGTAACAGAATTCCACTGCCGGTAC 
P6_F CGTGACGTGACCCGCCCTACAGCCGCGGGATTCAAACTCCCCCA
AGCGGTGTCCTGGTTGATACCCGCCCATCTTGG 
P6_R CTAGCCAAGATGGGCGGGTATCAACCAGGACACCGCTTGGGGGA
GTTTGAATCCCGCGGCTGTAGGGCGGGTCACGTCACGGTAC 
P7_F CGTTGGCTCTTAGTCCCCGCCCCCCCAAGACCTGCTTTTTGCAGC
CAATCGGCGGGCGCGGTGCCCGCCCATCTTGG 
P7_R CTAGCCAAGATGGGCGGGCACCGCGCCCGCCGATTGGCTGCAAA
AAGCAGGTCTTGGGGGGGCGGGGACTAAGAGCCAACGGTAC 
P8_F CCTTGTCCCGCCTCCCAACTTGGGGTGTCGCTGAATTTTCTGAG
GCCAGTCAAAGGGCAGGGTCCCGCCCATCTTGG 
P8_R CTAGCCAAGATGGGCGGGACCCTGCCCTTTGACTGGCCTCAGAA
AATTCAGCGACACCCCAAGTTGGGAGGCGGGACAAGGGTAC 
P9_F CTCTTTGGAGCGGCTCCCCTAGCCCCGCCCAGGACACCACGGTT
GGGGTCACGTGACAGCGCTCCCGCCCATCTTGG 
P9_R CTAGCCAAGATGGGCGGGAGCGCTGTCACGTGACCCCAACCGTG
GTGTCCTGGGCGGGGCTAGGGGAGCCGCTCCAAAGAGGTAC 
P10_F CCAGAGCCTCTACGCGGACCTGCCAGTCAGAGGGGAAGGCGGG
TTTTGGGGATACCTTGGGCCCCCGCCCATCTTGG 
	 40	
P10_R CTAGCCAAGATGGGCGGGGGCCCAAGGTATCCCCAAAACCCGCC
TTCCCCTCTGACTGGCAGGTCCGCGTAGAGGCTCTGGGTAC 
P11_F CCGCTTGGCAAGCAATACTTGTCGCCATCTTTGTTAGGGTCATGA
TGACTTGGGGCCGGGGCGCCCGCCCATCTTGG 
P11_R CTAGCCAAGATGGGCGGGCGCCCCGGCCCCAAGTCATCATGACC
CTAACAAAGATGGCGACAAGTATTGCTTGCCAAGCGGGTAC 
P12_F CCACACGGAAGCGTCGACACCTCCTGGAGAAAGAGAATCCTGCG
CAGCACTGTTGGGGAGATCCCCGCCCATCTTGG 
P12_R CTAGCCAAGATGGGCGGGGATCTCCCCAACAGTGCTGCGCAGGA
TTCTCTTTCTCCAGGAGGTGTCGACGCTTCCGTGTGGGTAC 
P13_F CCCGCAGTGCCCCAAGTACCGACACGCATGCACGCCCTCTGCCG
GGCGCCGAGCTGCAACCCCCGCCCATCTTGG 
P13_R CTAGCCAAGATGGGCGGGGGTTGCAGCTCGGCGCCCGGCAGAGG
GCGTGCATGCGTGTCGGTACTTGGGGCACTGCGGGGTAC 
P14_F CTTCCCCAAGTTTAGAGCTCGGCTTCTCCAACGCTGCCCTGCAC
GCCCATCACCGCGATTTCCCGCCCATCTTGG 
P14_R CTAGCCAAGATGGGCGGGAAATCGCGGTGATGGGCGTGCAGGG
CAGCGTTGGAGAAGCCGAGCTCTAAACTTGGGGAAGGTAC 
P15_F CTTTGTGGAGGACGCTCTGATTGGCTCCACCCCAACTCTTGGAC
CACACAGATCCTTGGCTCCCGCCCATCTTGG 
P15_R CTAGCCAAGATGGGCGGGAGCCAAGGATCTGTGTGGTCCAAGAG
TTGGGGTGGAGCCAATCAGAGCGTCCTCCACAAAGGTAC 
P16_F CCTTTTGGGGTCCCCCAAGCCGGCCTCGGACTGCGCATGCGTA
TAGTCAGCCGGCGTTTGATCCCCGCCCATCTTGG 
P16_R CTAGCCAAGATGGGCGGGGATCAAACGCCGGCTGACTATACGCA
TGCGCAGTCCGAGGCCGGCTTGGGGGACCCCAAAAGGGTAC 
P17_F CGTGCCGATCTCCCCCAAGTTATCTCTGCGCAGCCCCAAGAAG
GCAGGGAACCCCCAAGTACCCGCCCATCTTGG 
P17_R CTAGCCAAGATGGGCGGGTACTTGGGGGTTCCCTGCCTTCTTGGG
GCTGCGCAGAGATAACTTGGGGGAGATCGGCACGGTAC 
 
Table 2. ETS mutated sequences cloned in pGL3 basic for luciferase assay.  
The ETS site is highlighted in bold. 
 
 
 
Name Primer sequence 
P1_PU.1F CGCGCGTGCGTCTCTACCTCTGAAGAGGAAGTTTTCGCTTTG
CATAAAAGCGCTAGTCCGCTGCCCCGCCCATCTTGG 
P1_PU.1R CTAGCCAAGATGGGCGGGGCAGCGGACTAGCGCTTTTATGC
AAAGCGAAAACTTCCTCTTCAGAGGTAGAGACGCACGCGCG
GTAC 
P2_PU.1F CCGCGCGCGCAATTTCCGCCCGGGTCTCAGAGGAAGTTCCG
AGTCCCGGTACTGGAGGGTGCCCGCCCATCTTGG 
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P2_PU.1R CTAGCCAAGATGGGCGGGCACCCTCCAGTACCGGGACTCGG
AACTTCCTCTGAGACCCGGGCGGAAATTGCGCGCGCGGGTA
C 
P3_PU.1F CAGTCCCGCCCCGCAGGCGGTAGAGGAAGTGGCGGGCTGG
GATCAGCCTTTAAGATGGCGTCCCGCCCATCTTGG 
P3_PU.1R CTAGCCAAGATGGGCGGGACGCCATCTTAAAGGCTGATCCC
AGCCCGCCACTTCCTCTACCGCCTGCGGGGCGGGACTGGTAC 
P4_PU.1F CGGTCGGCCGCTACTTCCTCTAAGTAACTGCGCCTGGGTCA
CGGCGCAAGCGCAAACTACGCCCGCCCATCTTGG 
P4_PU.1R CTAGCCAAGATGGGCGGGCGTAGTTTGCGCTTGCGCCGTGAC
CCAGGCGCAGTTACTTAGAGGAAGTAGCGGCCGACCGGTAC 
P7_PU.1F CGTTGGCTCTTAGTCCCCGCCAGAGGAAGTCCTGCTTTTTGC
AGCCAATCGGCGGGCGCGGTGCCCGCCCATCTTGG 
P7_PU.1R CTAGCCAAGATGGGCGGGCACCGCGCCCGCCGATTGGCTGC
AAAAAGCAGGACTTCCTCTGGCGGGGACTAAGAGCCAACGG
TAC 
P8_PU.1F CCTTGTCCCGCCTCCCAACTTCCTCTGTCGCTGAATTTTCTG
AGGCCAGTCAAAGGGCAGGGTCCCGCCCATCTTGG 
P8_PU.1R CTAGCCAAGATGGGCGGGACCCTGCCCTTTGACTGGCCTCAG
AAAATTCAGCGACAGAGGAAGTTGGGAGGCGGGACAAGGGT
AC 
P9_PU.1F CTCTTTGGAGCGGCTCCCCTAGCCCCGCCCAGGACACCACAC
TTCCTCTCACGTGACAGCGCTCCCGCCCATCTTGG 
P9_PU.1R CTAGCCAAGATGGGCGGGAGCGCTGTCACGTGAGAGGAAGT
GTGGTGTCCTGGGCGGGGCTAGGGGAGCCGCTCCAAAGAGG
TAC 
P11_PU.1F CCGCTTGGCAAGCAATACTTGTCGCCATCTTTGTTAGGGTCA
TGATGACTTCCTCTCGGGGCGCCCGCCCATCTTGG 
P11_PU.1R CTAGCCAAGATGGGCGGGCGCCCCGAGAGGAAGTCATCATG
ACCCTAACAAAGATGGCGACAAGTATTGCTTGCCAAGCGGG
TAC 
P16_PU.1F CCTTTTCCTCTAGAGGAAGTCGGCCTCGGACTGCGCATGCG
TATAGTCAGCCGGCGTTTGATCCCCGCCCATCTTGG 
P16_PU.1R CTAGCCAAGATGGGCGGGGATCAAACGCCGGCTGACTATAC
GCATGCGCAGTCCGAGGCCGACTTCCTCTACCGGAAAAGGG
TAC 
P17_PU.1F CGTGCCGATCTAGAGGAAGTTATCTCTGCGCAAGAGGAAGT
AGGCAGGGAAAGAGGAAGTACCCGCCCATCTTGG 
P17_PU.1R CTAGCCAAGATGGGCGGGTACTTCCTCTTTCCCTGCCTACTTC
CTCTTGCGCAGAGATAACTTCCTCTAGATCGGCACGGTAC 
 
Table 3. Elf-to-PU.1 sequences cloned in pGL3 basic for luciferase assay.  
The PU.1 site is highlighted in bold. 
 
 
Name Primer sequence 
E1_F CGTTAACTGTGACAGTGTCACTTCCGGGACTTCCTGGAGGCCTC
TGGGAGACACAGAGCTGTCATGTGGGATCCCCCGCCCATCTTGG 
	 42	
E1_R CTAGCCAAGATGGGCGGGGGATCCCACATGACAGCTCTGTGTCT
CCCAGAGGCCTCCAGGAAGTCCCGGAAGTGACACTGTCACAGTT
AACGGTAC 
E2_F CGTTAACTTCCATCTGCTGAGACCACTTCCGGGCTCCCAGAGTG
AACAGAAGCTTGGCTTCCTGTGAGGGATCCCCCGCCCATCTTGG 
E2_R CTAGCCAAGATGGGCGGGGGATCCCTCACAGGAAGCCAAGCTTC
TGTTCACTCTGGGAGCCCGGAAGTGGTCTCAGCAGATGGAAGTT
AACGGTAC 
E3_F CGTTAACCAGACGCAGTAGCACCCGGAAGTGAAGTCCGGACTC
CTCTCCTCTTTCTTCCTGCTGGAGGGGATCCCCCGCCCATCTTGG 
E3_R CTAGCCAAGATGGGCGGGGGATCCCCTCCAGCAGGAAGAAAGAG
GAGAGGAGTCCGGACTTCACTTCCGGGTGCTACTGCGTCTGGTTA
ACGGTAC 
E4_F CGTTAACCCCAATTCTGTGGAAATCCCCGGAAGCTGGCAGCTGC
ATCTCTACCCGCTCTCCTTTGGTTGGATCCCCCGCCCATCTTGG 
E4_R CTAGCCAAGATGGGCGGGGGATCCAACCAAAGGAGAGCGGGTA
GAGATGCAGCTGCCAGCTTCCGGGGATTTCCACAGAATTGGGGTT
AACGGTAC 
E5_F CGTTAACTCAAGAGGAAGTGTGCCACCTACTGACTCCCAGAAAC
CACTTCCGGTGGCTGTTTGGTTTAGGATCCCCCGCCCATCTTGG 
E5_R CTAGCCAAGATGGGCGGGGGATCCTAAACCAAACAGCCACCGGA
AGTGGTTTCTGGGAGTCAGTAGGTGGCACACTTCCTCTTGAGTTA
ACGGTAC 
E6_F CGTTAACTCAGATCTGCCCTGTCCTCTGCTTCCGGTATCTCTATT
CCACTTCTGCTTTCTCCTCTAAGGGATCCCCCGCCCATCTTGG 
E6_R CTAGCCAAGATGGGCGGGGGATCCCTTAGAGGAGAAAGCAGAA
GTGGAATAGAGATACCGGAAGCAGAGGACAGGGCAGATCTGAG
TTAACGGTAC 
E7_F CGTTAACAAATACCGGAAGCCCAGCACAGCTAGTTCTTGTGTTT
GCTCACAGAAAACAGGAACAGAAGGGATCCCCCGCCCATCTTGG 
E7_R CTAGCCAAGATGGGCGGGGGATCCCTTCTGTTCCTGTTTTCTGTG
AGCAAACACAAGAACTAGCTGTGCTGGGCTTCCGGTATTTGTTAA
CGGTAC 
E8_F CGTTAACACAGAAGCCTCCGTGGAGTTCCTTCCGGTAGGGCTGG
TGTTCCTTTTCCAGAGCGTTTCCTGGATCCCCCGCCCATCTTGG 
E8_R CTAGCCAAGATGGGCGGGGGATCCAGGAAACGCTCTGGAAAAGG
AACACCAGCCCTACCGGAAGGAACTCCACGGAGGCTTCTGTGTT
AACGGTAC 
E9_F CGTTAACAGAGGAAGTACACTCATAGCTGCCTGGGGCTGGGAGT
TGTAGAGAAACCGGAAGGGAGCAGGGATCCCCCGCCCATCTTG
G 
E9_R CTAGCCAAGATGGGCGGGGGATCCCTGCTCCCTTCCGGTTTCTCT
ACAACTCCCAGCCCCAGGCAGCTATGAGTGTACTTCCTCTGTTAA
CGGTAC 
E10_F CGTTAACCAAAGAGGAAGTGCTGACGAGAGAACCGGAAGTGAC
AGGCCTAAGCCTGATGCAGTTTTGCGGATCCCCCGCCCATCTTGG 
E10_R CTAGCCAAGATGGGCGGGGGATCCGCAAAACTGCATCAGGCTTA
GGCCTGTCACTTCCGGTTCTCTCGTCAGCACTTCCTCTTTGGTTAA
CGGTAC 
E11_F CGTTAACAGTGCCCCTGGTGTTAATGTCAGTGAAGGACAGAGCG
GAAGTGTCCTGTTTGTTTTAGCTGGGATCCCCCGCCCATCTTGG 
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E11_R CTAGCCAAGATGGGCGGGGGATCCCAGCTAAAACAAACAGGACA
CTTCCGCTCTGTCCTTCACTGACATTAACACCAGGGGCACTGTTA
ACGGTAC 
E12_F CGTTAACCTTGTAATCATGAACTAGACCTTCCCCGGAAGTACTG
ACTTCCTCCCAGCACACATCCTGAGGATCCCCCGCCCATCTTGG 
E12_R CTAGCCAAGATGGGCGGGGGATCCTCAGGATGTGTGCTGGGAGG
AAGTCAGTACTTCCGGGGAAGGTCTAGTTCATGATTACAAGGTTA
ACGGTAC 
E13_F CGTTAACAACCCTCAGCACTTCCGCTTTTTTTCTTATATAGTTGT
GGCAACCATGTTGTGCCTGCTGGGGATCCCCCGCCCATCTTGG 
E13_R CTAGCCAAGATGGGCGGGGGATCCCCAGCAGGCACAACATGGTT
GCCACAACTATATAAGAAAAAAAGCGGAAGTGCTGAGGGTTGTT
AACGGTAC 
E14_F CGTTAACCCGTTCTTCCTCCGCCCAGCCTGGCAACCCCCGCTCCA
CTTCCGCTTCCAGGAGTCTGGCCGGATCCCCCGCCCATCTTGG 
E14_R CTAGCCAAGATGGGCGGGGGATCCGGCCAGACTCCTGGAAGCGG
AAGTGGAGCGGGGGTTGCCAGGCTGGGCGGAGGAAGAACGGGT
TAACGGTAC 
E15_F CGTTAACTAAGTCACTTCCGCTTCTTGAGCTACAGGAAGTGTGA
GGTCAGAGATGTTTGGTCCTGTTTGGATCCCCCGCCCATCTTGG 
E15_R CTAGCCAAGATGGGCGGGGGATCCAAACAGGACCAAACATCTCT
GACCTCACACTTCCTGTAGCTCAAGAAGCGGAAGTGACTTAGTTA
ACGGTAC 
 
Table 4. Enhancer sequences cloned in pGL3 basic for luciferase assay.  
The Elf site is highlighted in bold. 
 
Wild type and Inr-Sp1 mutated synthetic core promoters were cloned in pGL3-basic vector 
between NheI and NcoI sites, sequences are listed in Table 5 (wild type) and Table 6 (Inr-
Sp1 mutated).  
 
Name Primer Sequence 
Synt_1_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCTAAGTAAGC
TTGGCATTCCGGTACTGTTGGTAAACCCGCCCATCTTGC 
Synt_1_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATGC
CAAGCTTACTTAGATCGCAGATCTCGAGCCCGGATCGCG 
Synt_2_F CTAGCCCCGGAAGTGCGATCCGGGCTCGAGATCTGCGATC
TAAGTAAGCTTGGCATTCCGGTACTGTTGGTAAACCCGCC
CATCTTGC 
Synt_2_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATGC
CAAGCTTACTTAGATCGCAGATCTCGAGCCCGGATCGCAC
TTCCGGGG 
Synt_3_F CTAGCGCGATCCGGCCCGGAAGTGCTCGAGATCTGCGATC
TAAGTAAGCTTGGCATTCCGGTACTGTTGGTAAACCCGCC
CATCTTGC 
Synt_3_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATGC
CAAGCTTACTTAGATCGCAGATCTCGAGCACTTCCGGGCC
GGATCGCG 
Synt_4_F CTAGCGCGATCCGGGCTCGAGATCTCCCGGAAGTGCGATC
TAAGTAAGCTTGGCATTCCGGTACTGTTGGTAAACCCGCC
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CATCTTGC 
Synt_4_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATGC
CAAGCTTACTTAGATCGCACTTCCGGGAGATCTCGAGCCC
GGATCGCG 
Synt_5_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCTAAGCCCGG
AAGTTAAGCTTGGCATTCCGGTACTGTTGGTAAACCCGCC
CATCTTGC 
Synt_5_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATGC
CAAGCTTAACTTCCGGGCTTAGATCGCAGATCTCGAGCCC
GGATCGCG 
Synt_6_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCTAAGTAAGC
TTGGCCCCGGAAGTATTCCGGTACTGTTGGTAAACCCGCC
CATCTTGC 
Synt_6_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATAC
TTCCGGGGCCAAGCTTACTTAGATCGCAGATCTCGAGCCC
GGATCGCG 
Synt_7_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCTAAGTAAGC
TTGGCATTCCGGTACTCCCGGAAGTGTTGGTAAACCCGCC
CATCTTGC 
Synt_7_R CATGGCAAGATGGGCGGGTTTACCAACACTTCCGGGAGTA
CCGGAATGCCAAGCTTACTTAGATCGCAGATCTCGAGCCC
GGATCGCG 
Synt_8_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCTAAGTAAGC
TTGGCATTCCGGTACTGTTGGTAAACCCGGAAGTCCCGCC
CATCTTGC 
Synt_8_R CATGGCAAGATGGGCGGGACTTCCGGGTTTACCAACAGTA
CCGGAATGCCAAGCTTACTTAGATCGCAGATCTCGAGCCC
GGATCGCG 
Synt_PU.1_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCTAAGTAAGC
TTGGCAGAGGAAGTATTCCGGTACTGTTGGTAAACCCGCC
CATCTTGC 
Synt_PU.1_R CATGGCAAGATGGGCGGGTTTACCAACAGTACCGGAATAC
TTCCTCTGCCAAGCTTACTTAGATCGCAGATCTCGAGCCCG
GATCGCG 
 
Table 5. Wild-type synthetic promoter sequences cloned in pGL3 basic for luciferase assay.  
 
Name  Primer Sequence 
Synt_1 Mut Inr_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCT
AAGTAAGCTTGGCATTCCGGTACTGTTGGTAA
ACCCGCCCTTCTTGC 
Synt_1 Mut Inr_R CATGGCAAGAAGGGCGGGTTTACCAACAGTAC
CGGAATGCCAAGCTTACTTAGATCGCAGATCT
CGAGCCCGGATCGCG 
Synt_1 w/o Sp1_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCT
AAGTAAGCTTGGCATTCCGGTACTGTTGGTAA
ACCATCTTGC 
Synt_1 w/o Sp1_R CATGGCAAGATGGTTTACCAACAGTACCGGAA
TGCCAAGCTTACTTAGATCGCAGATCTCGAGC
CCGGATCGCG 
Synt_1 w/o Sp1 Mut Inr_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCT
AAGTAAGCTTGGCATTCCGGTACTGTTGGTAA
ACCTTCTTGC 
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Synt_1 w/o Sp1 Mut Inr_R CATGGCAAGAAGGTTTACCAACAGTACCGGAA
TGCCAAGCTTACTTAGATCGCAGATCTCGAGC
CCGGATCGCG 
Synt_5 Mut Inr_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCT
AAGTAAGCTTGGCATTCCGGTACTGTTGGTAA
ACCCGGAAGTCCCGCCCTTCTTGC 
Synt_5 Mut Inr_R CATGGCAAGAAGGGCGGGACTTCCGGGTTTAC
CAACAGTACCGGAATGCCAAGCTTACTTAGAT
CGCAGATCTCGAGCCCGGATCGCG 
Synt_5 w/o Sp1_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCT
AAGTAAGCTTGGCATTCCGGTACTGTTGGTAA
ACCCGGAAGTCCATCTTGC 
Synt_5 w/o Sp1_R CATGGCAAGATGGACTTCCGGGTTTACCAACA
GTACCGGAATGCCAAGCTTACTTAGATCGCAG
ATCTCGAGCCCGGATCGCG 
Synt_5 w/o Sp1 Mut Inr_F CTAGCGCGATCCGGGCTCGAGATCTGCGATCT
AAGTAAGCTTGGCATTCCGGTACTGTTGGTAA
ACCCGGAAGTCCTTCTTGC 
Synt_5 w/o Sp1 Mut Inr_R CATGGCAAGAAGGACTTCCGGGTTTACCAACA
GTACCGGAATGCCAAGCTTACTTAGATCGCAG
ATCTCGAGCCCGGATCGCG 
 
Table 6. Inr-Sp1 mutated synthetic promoter sequences cloned in pGL3 basic for luciferase 
assay.  
 
 
4.4 Transient Transfections and Luciferase Assays 
 
Transient transfections were performed using Lipofectamine Plus (Invitrogen) according to 
the manufacturer’s protocol. 
RAW264.7 cells were transiently transfected in a 24-well format (150 x 103 cells/well) 
with 150 ng of empty vector or vectors containing the specified genomic region, together 
with 50 ng of pRL-TK-renilla vector (Promega). Hepa 1-6 and L-Wnt-3A cells were 
transiently transfected in a 48-well format (30 x 103 cells/well) with 50 ng of promoter 
vector and 25 ng of the pRL-TK-renilla vector. The luciferase assay (Dual-Glo Luciferase 
Assay System, Promega) was performed twenty-four hours after transfection. Values were 
normalized on the Renilla signal and expressed as fold change relative to the empty vector. 
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4.5 Western blot 
Macrophage cells were harvested and washed once in 1x PBS, then lysed in Ripa buffer 
(10mM Tris-HCl pH 8.0, 1mM EDTA,140 mM NaCl, 10% Triton x-100, 10% SDS, 10% 
DOC). 30 ug of protein were used to analyze the level of expression of RNApolII and 
ELF4 through sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). 
The gel was transferred to a PVDF transfer membrane and blocked with 0,5% BSA in 1x 
TBST. Rpb1 (Santa Cruz sc-899), ELF4 (home made), INTS10 (Origene, TA337360), 
NELFB (Proteintech, 16418-1-AP), Chd1 (Novus, NB100-60411) and anti-vinculin 
(Sigma) antibody were revealed with the ECL western blotting detection reagents 
(Amersham), according to manufacturer’s protocol.  
 
  4.6 Nuclear Extract for pull-down experiment 
RAW 264.7 cells were lysated with a 2-step nuclear extraction protocol. Cells were 
harvested and washed once in 1x PBS, then lysed in Buffer A (50 mM Tris-HCl pH 8.0, 2 
mM EDTA, 0,1% NP40, 10% glycerol), incubated for 5 minutes at 4°C and centrifuged 5 
minutes at 4°C, 3000 RPM (3 times the volume of cell pellet was used to resuspend cells). 
The surnatant was kept as cytosol fraction. The pellet was resuspended in Buffer B (250 
mM NaCl, 50 mM Tris-HCl pH 8.0, 0,5 mM EDTA, 0,5 mM EGTA, 0,2% NP40), 
incubated by rotation 10 minutes at 4°C and centrifuged 5 minutes at 4°C, 13000 RPM. 
The surnatant was collected as “first nuclear extract”. The obtained pellet was resuspended 
in Buffer C (420 mM NaCl, 20mM Hepes KOH pH 7.9, 20% glycerol, 2 mM MgCl2, 0,2 
mM EDTA, 0,1% NP40), incubated 1 hr by rotation at 4°C and centrifuged 1 hr at 33000 
RPM. The surnatant was collected as “second nuclear extract” and joined to the “first 
nuclear extract”. This combined nuclear extract was used for the pull-down (PD) 
experiment.  
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4.7 Pulldown experiment  
160 µl of myone C1 beads (invitrogen) were washed twice with 500 µl of DNA Binding 
Buffer (DBB containing 1 M NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0,05% NP40). 
50 pmol of wild-type or mutated DNA were conjugated with the beads by rotation for 1 hr 
at 4°C. The primers used to amplify a region of 240 bp containing the ETS site are shown 
below (Table 7). Bead-immobilized DNAs were then washed twice with 500 µl DBB and 
twice with 500 µl of Protein Binding Buffer (PBB containing 150 mM NaCl, 50 mM Tris-
HCl pH 8.0, 10 mM MgCl2, 0,5% NP40, 0,2 µg/µl salmon sperm). 400 µg of nuclear 
extract form RAW 264.7 cells (see below) were added to respuspended beads, pull-down 
were performed in a final volume of 600 µl in PBB and incubated by rotation for 2 hr at 
4°C. 30 µl of flow-through (FT) from pull-down with  wild-type and mutated DNA were 
collected. Beads were washed twice using 500 µl ice-cold PBB, resuspended in 30 µl of 
NuPage-LDS (Invitrogen) and boiled 5 minutes at 95°C. 10 µg of Raw nuclear extract, 3 
µl of samples and 30 µl of FT were loaded on SDS-PAGE gel for western blot detection, 
whereas 27 µl were loaded on precast gel (NuPage Novex 4-12%, 1,5 mm, Invitrogen). 
 
Name Primer Sequence 
Pull-down_F GCGGTACCTTCGTGAGACCCTGGATTCT 
Pull-down_R GCGCTAGCCGCTACTGCCTTTGGTCACT 
Pull-down_Mut_F CGGCTGCCTTGCTCCCCCAAGTGGAGGGTTTACAC 
Pull-down_Mut_R GTGTAAACCCTCCACTTGGGGGAGCAAGGCAGCCG 
Desthiobiot TEG/GTGCAGGTGCCAGAACATTT 
 
Table 7. Primers for pull-down bait cloning. 
The first fourth primers were used to clone wild-type and mutated Elf site in to pGL3-basic vector. 
Desthiobiot and pull-down_R primers were used to amplify the wild type and mutated DNA bait from the 
pGL3-basic vector.  
 
4.8 In-Gel protein digestion 
Gel-separated proteins were sliced, de-stained in 50% v/v acetonitrile Ammonium 
Bicarbonate (AmBic) 50 mM, reduced with 10 mM DTT in 50 mM AmBic for one hour at 
56°C and subsequently alkylated with 55 mM iodoacetamide in 50 mM AmBic for 45 min 
at RT in dark. After each step samples were dehydrated with 100% ethanol and quickly 
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‘‘dried’’ in a centrifugal evaporator (SpeedVac). Subsequently, gel pieces were washed 
extensively with 50 mM AmBic and digested with 12.5 ng mL1 trypsin (Promega V5113) 
in 50 mM AmBic overnight at 37°C. Digested peptides were extracted with extraction 
buffer (3% TFA, 30% ACN) and 100% ACN. Lyophilized samples were desalted and 
concentrated on C18 Stage Tips. The elution was carried out with a highly organic solvent 
(80% ACN) followed by lyophilisation. Prior to LC-MS/MS analysis, samples were re-
suspended in 1% TFA in ddH2O. 
 
4.9 Liquid chromatography and tandem mass spectrometry  
      (LC-MSMS) 
Peptide mixtures were separated by online nano-flow liquid chromatography using an 
EASY-nLC™ 1000 system (Thermo Fisher Scientific, Odense, Denmark) directly 
connected to a QExactive instrument (Thermo Fisher Scientific) through a 
nanoelectrospray ion source. The nano LC system was operated in a one-column set-up 
with a 25 cm analytical column (75 µm inner diameter, 350 µm outer diameter) packed 
with C18 resin (ReproSil, Pur C18AQ 1.9 µm, Dr. Maisch, Germany). Solvent A was 
0.1% FA and 5% ACN in ddH2O and solvent B was 80% ACN with 0.1% FA. Samples 
were injected in an aqueous 1% TFA solution at a flow rate of 500 nl/min. Peptides were 
separated with a gradient of 0–30% ACN solvent B over 73 min, followed by a gradient 
30-60% ACN in 10 min and 60-95% in 1 min at a flow rate of 250 nl/min in the EASY-
nLC 1000 system. The Q Exactive instrument was operated in the data-dependent mode 
(DDA) to automatically switch between full scan MS and MSMS acquisition. Survey full 
scan MS spectra (from m/z 300-1650) were analyzed in the Orbitrap detector with 
resolution R=60,000 at m/z 200. The fifteen most intense peptide ions with charge states 
≥2 were sequentially isolated to a target value of 3e6 and fragmented by Higher Energy 
Collision Dissociation (HCD), with a normalized collision energy setting of 27%. The 
maximum allowed ion accumulation times were 20 ms for full scans and 65 ms for MSMS 
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and the target value for MSMS was set to 1e5 (R=15,000 at m/z 200). The dynamic 
exclusion and the isolation window were set to 20s and 1.4 Da, respectively. Standard 
mass spectrometric conditions for all experiments were: spray voltage, 2.4 kV; no sheath 
and auxiliary gas flow. 
 
4.10 Assay for Transposase-Accessible Chromatin (ATAC-seq)  
The original ATACseq protocol (Buenrostro et al., 2013) was modified according to Lara-
Astiaso et al. (Lara-Astiaso et al., 2014). First of all, Tn5 transposase was loaded with 
sequencing adapters (0,125 µl sequencing adapters, 0,4 µl glycerol 100%, 1,2 µl dialysis 
buffer, 3,6 µl Tn5 transposase) in a single tube reaction for 1 h at room temperature 
(Dialysis buffer: 100 mM Hepes KOH pH 7.2, 0.2 M NaCl , 0.2 mM EDTA, 2 mM DTT, 
0.2% Triton, 20% glycerol). 50 X 103 cells were pelleted by centrifugation and re-
suspended in 25 µl of cold lysis buffer (10mM Tris-HCl pH 7.4, 10mM NaCl, 3mM 
MgCl2, 0.1% Igepal CA-630). Nuclei were pelleted by centrifugation for 20 min at 500g, 
4 ºC.  The supernatant was discarded and nuclei were re-suspended in 25 µl of reaction 
buffer containing 1 µl of Tn5 transposase (made in house) and 5x transposase buffer 
(50mM Tris-HCl, pH 8.4 and 25mM MgCl2). The reaction was incubated at 37ºC for one 
hour. Then 5 µl of clean up buffer (900mM NaCl, 300mM EDTA), 2ul of 5% SDS and 2 
µl of Proteinase K (20 µg/µl) (New England Biolabs) were added and incubated for 30 min 
at 40 ºC. Tagmented DNA was isolated using SPRI beads (2x). For library amplification, 
two sequential PCR reactions were performed in order to enrich small tagmented DNA 
fragments. We used 2 µl of indexing primers and KAPA HiFi HotStart ready mix. PCR 
conditions are reported below). After the first PCR, fragments smaller than 600 bp were 
isolated using SPRI cleanup and a second PCR was performed using the same conditions 
in order to obtain the final library. DNA concentration was measured with a Qubit 
fluorometer (Life Technologies) and library quality was analyzed using a Bioanalyzer 
(Agilent Technologies). Libraries where sequenced on an Illumina HiSeq 2000. 
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1° PCR conditions: 
 
72°C for 5’ 
98°C for 2’ 
98°C for 20’’ 
63°C for 30’’ 
72°C for 1’ 
4°C for ∞ 
 
2° PCR conditions: 
 
72°C for 5’ 
98°C for 2’ 
98°C for 20’’ 
63°C for 30’’ 
72°C for 1’ 
4°C for ∞ 
 
* The number of cycles is determined by the quantity of DNA obtained with the first PCR. 
If it is less than 0.9 ng/ul, 6 cycles are required; otherwise, if it is more than 0.9 ng/ul, 5 
cycles are sufficient.  
 
4.11 CRISPR/Cas9 genome editing  
Single-guide sequences specific to the ETS site of Cep55, Fuz, Acyp1 and Pcgf1 core 
promoters (showed in Table 8) were designed using the CRISPR design tool 
(http://tools.genome-engineering.org) and cloned into lentiCRISPRv2 (Sanjana et al., 
2014). After RAW264.7 infection, single cells were seeded in 96-well plates by dilution 
and expanded. Clones were first screened evaluating gene expression by QPCR 
(expression primers are listed in Table 9 and positive clones were subjected to Sanger 
sequencing. 
 
 
Name Primer sequence 
Fuz_F (phospho)CACCGGTTAGGGTCATGATGACTTC 
Fuz_R (phospho)AAACGAAGTCATCATGACCCTAACC 
Cep55_F (phospho)CACCGGGGATTCAAACTCCCGGAAG 
Cep55_R (phospho)AAACCTTCCGGGAGTTTGAATCCCC 
Acyp1_F (phospho)CACCGGAAGCCGAGCTCTAAACTTC 
Acyp1_R (phospho)AAACGAAGTTTAGAGCTCGGCTTCC 
9 cycles 
n cycles* 
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Pcgf1_F (phospho)CACCGTGATCCCAGCCCGCCACTTC 
Pcgf1_R (phospho)AAACGAAGTGGCGGGCTGGGATCAC 
 
Table 8. Genome editing primers. 
Primers used to clone the single-guide sequences. 
 
Name Primer sequence 
Fuz_F GACCCAGTGTGTGGACTGTG 
Fuz_R ACCACTCGGCCTGATACAAG 
Cep55_F CGCCAGAATATGCAGCATCA 
Cep55_R TGGCTGCTCTGTGATGGTAA 
Acyp1_F TCAGGCTGAGGGTAAAAAGC 
Acyp1_R ATGAAGCGCACCTTGGAG 
Pcgf1_F CTCAAACTGGATCGGGTCAT 
Pcgf1_R CTGTCTAAGCCTCGGGACTG 
 
Table 9. qPCR primers 
Primers used to check the level of mRNA expression. 
 
 
4.12 Computational methods 
4.12.1 Motif enrichment analysis  
In order to identify over-represented motifs corresponding to known TF-binding sites, 
Pscan (Zambelli et al., 2009) was performed with 3041 models (position weight matrices, 
PWM) collected from public repositories and literature: HOCOMOCO database v10 
(Kulakovskiy et al., 2016), JASPAR database (Mathelier et al., 2016; Diaferia et al., 2016; 
Jolma et al., 2015). Foreground: nascent expressed transcripts (FPKM > 2) from bone 
marrow macrophages were used. Refseq TSSs were used as background.  
 
4.12.2 ChIP-seq data analysis 
Quality control checks on raw sequence data were performed with FastQC v0.11.2 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Adapter trimming and quality 
filtering were carried out with Trimmomatic v0.32 (Bolger et al., 2014). Reads were 
mapped to the mm10 (GRCm38) mouse reference genome using Bowtie2 v2.2.4 
(Langmead and Salzberg, 2012). Alignments with low mapping quality (MAPQ<10) and 
PCR duplicates were removed with Samtools v0.1.19 (Li et al., 2009). Peak calling was 
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performed using MACS2 2.1.0 (Zhang et al., 2008). Each ChIP was compared to input 
DNA. Enriched regions ("peaks") were filtered by q-value < 0.01 and fold enrichment > 4. 
Peaks corresponding to blacklisted regions identified by the ENCODE project 
(Consortium, 2012) were discarded. In order to visualize the raw profiles on the UCSC 
Genome Browser, BedGraph files generated by MACS2 were converted to BigWig files 
(Kent et al., 2010) with the wigToBigWig v4 tool of the UCSC Genome Browser Utilities 
(Kuhn et al., 2013). Tag counts values were transformed in RPM (reads per million) for 
visualization. 
 
4.12.3 Peaks genomic distribution  
Gene Interval Notator (GIN) (Cesaroni et al., 2008) was used to annotate all peaks over 
mm10 Ensembl genes release v83 (Cunningham et al., 2015). GIN was run with priority 
set to “gene” and “-20000” as promoter definition.  
 
4.12.4 Histogram of distances between ChIP-seq peaks to the nearest TSS  
Transcription start sites were downloaded from the Ensembl mm10 release v83 
(Cunningham et al., 2015). Only peaks with at least one TSS within -10/+10 kb were 
considered. Distances between peaks summit and the nearest transcription start sites were 
obtained using Bedtools closest v2.19.1 (Quinlan, 2014). Each bin in the histogram 
represents a 50 bp region. 
 
4.12.5 De novo motif discovery  
We ran MEME v4.11.0 (Bailey et al., 2009) considering a window of +/- 100 nucleotides 
surrounding the summit of the top 3000 peaks (as determined by MACS2 fold 
enrichment). The following parameters were used: -dna -mod zoops -evt 0.01 -nmotifs 10 -
minw 6 -maxw 14 –revcomp. 
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4.12.6 Functional enrichment analysis of ChIP-Seq enriched regions using GREAT.  
For each sample, the top 3000 peaks (as determined by MACS2 fold enrichment) were 
analyzed by GREAT v3.0.0 (McLean et al., 2010) with default parameters and selecting 
the whole mm10 genome as background. For each analysis, the top 10 "Biological 
Processes" according to the best Binomial False Discovery Rate (FDR Binom) were 
selected, and values were transformed to positive scores as -10*log10 of FDR Binom. 
Score values were subject to unsupervised hierarchical clustering (method=average; 
distance=Pearson correlation). To avoid any bias due to the outliers, a saturation procedure 
was performed: scores exceeding the 80th percentile were set to this value. 
 
4.12.7 Beeswarm plot of gene expression  
Gene expression data from different cell types and tissues were obtained from published 
microarray dataset (Tippmann et al., 2012). Only genes expressed in at least one sample 
were considered (log of intensity > 7). Transcription start sites were downloaded from the 
Eukaryotic Promoter Database (EPDnew Mouse v002) (Dreos et al., 2013) and genomic 
coordinates were converted to the mm10 Mouse genome release with the liftOver program 
included in the UCSC Genome Browser Utilities. 
 
4.12.8 RNA-seq data analysis 
Quality control checks on raw sequence data was performed with FastQC v0.11.2. After 
quality filtering according to the Illumina pipeline, reads were aligned to the mm10 
(GRCm38) mouse reference genome with TopHat v2.1.0 (Kim et al., 2013) and Bowtie 
v2.2.4 (Langmead and Salzberg, 2012) using the list of Refseq genes downloaded from 
UCSC Table Browser (Kuhn et al., 2013). Transcript abundance and differentially 
expressed genes were called using Cufflinks and Cuffdiff 2.2.1 (Trapnell et al., 2013). 
Reads from chrM and known rRNA or tRNA were discarded (data from UCSC Table 
Browser). During transcript quantification we used options –N (which specifies for upper-
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quartile normalization) and -u (which allows a better weighting of multi-mapping reads). 
Tracks for the UCSC Genome Browser were generated from bam files with Bedtools 
genomecov v2.19.1 (Quinlan, 2014) and wigToBigWig v4 (Kuhn et al., 2013). Tag counts 
values were transformed in RPM.  
 
4.12.9 Coverage profiles of ChIP-Seq data 
Tag counts were obtained from BedGraph files produced by MACS2. Input counts from 
the same genomic regions were subtracted and final values were normalized from 0 to 1. 
 
4.12.10 Relative enrichment plot 
FIMO (Grant et al., 2011) was run over the entire mm9 genomic sequence looking for 
matches (p-value <= 1e-4) to published position weight matrices (PWMs) for the core 
promoter elements TATA box and Initiator (Inr)(Jin et al., 2006) as well as for the TF 
ELF4 (Wei et al., 2010). These maps were used to estimate the spatial density of these 
sequence motifs with respect to the annotated TSSs of EDPnew genes. On the other hand, 
ChIP-seq coverage for ELF4 and polII binding was instead calculated starting from the 
raw reads. These were consistently extended to 200 bps. PCR duplicates were filtered. 
Coverage was estimated using custom C++ scripts. A sliding window of 10 bp was applied 
across a 10 kbp region, centered on the considered TSSs. The relative density of the signal 
from each dataset (either motif or ChIP-seq prediction) was then estimated using the entire 
10 kbp region. R was used to generate plots. 
 
4.12.11 Scatterplot of ChIP-Seq regions  
The number of reads for each region was normalized based on the sequencing depth of the 
least sequenced sample. Counts were normalized based on the size of the region in kbp and 
log2-transformed. Each dot was colored accordingly to the enrichment between the two 
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samples (fold change >  2) of the corresponding region (Red: enriched in treated; Blue: 
enriched in untreated; Grey: no enrichment).  
 
4.12.12 Scatterplot of motif occurrences in ChIP-Seq peaks  
Using the position weight matrix (PWM) of SPI1 (SPI1_HUMAN.H10MO.A) and ELF4 
(ELF1_HUMAN.H10MO.A) obtained from the HOCOMOCO database (Kulakovskiy et 
al., 2016), the genomic regions of interest were scanned using FIMO (version included in 
MEME Suite v4.11.10) (Grant et al., 2011) with a p-value threshold of 1e-03. For each 
region, the best matches (by lowest p-value) for each of the two PWMs were selected and 
values were transformed to positive scores (-10*log10 of p-values). Each dot represents a 
genomic region. Darker colors indicate higher density. 
 
4.12.13 ATAC-seq data analysis  
Quality control checks on raw sequence data were performed with FastQC v0.11.2. 
Adapter trimming and quality filtering was carried out with Trimmomatic v0.32 (Bolger et 
al., 2014). Reads were mapped to the mm10 (GRCm38) reference mouse genome using 
Bowtie2 v2.2.4 (Langmead and Salzberg, 2012). Alignments with low mapping quality 
(MAPQ<10), PCR duplicates and reads aligned to chrM were removed with Samtools 
v0.1.19 (Li et al., 2009). Reads aligning to the forward strand were offset by +4 bp, and 
reads aligning to the reverse strand were offset −5 bp as described in Buenrostro et al. 
2013 (Buenrostro et al., 2013). Peak calling was performed using MACS2 2.1.0 (Zhang et 
al., 2008). In order to visualize the raw profiles on the UCSC Genome Browser (Kuhn et 
al., 2013), BedGraph files generated by MACS2 were converted to BigWig files (Kent et 
al., 2010) with wigToBigWig v4 (Kuhn et al., 2013). Tag counts values were transformed 
in RPM. 
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4.12.14 Protein identification by MaxQuant software and data analysis  
The mass spectrometric raw data were analyzed with the MaxQuant software (version 
1.5.2.8) (http://www.maxquant.org/downloads.htm)(Cox and Mann, 2008), using the 
Andromeda search engine (Cox et al., 2011). A false discovery rate (FDR) of 1% for 
proteins and peptides was applied, and a minimum peptide length of 6 amino acids was 
required. The MOUSE 1401 database (51195 entries) was used for peptide identification. 
Enzyme specificity was set to Trypsin and maximum of two missed cleavages were 
allowed. The main search was performed with a mass tolerance of 6 ppm. Cysteine 
carbamidomethylation (Cys+57.021464 Da) was searched as fixed modification, whereas 
N-acetylation of protein (N-term, +42.010565 Da) and oxidized Methionine (+15.994915 
Da) were searched as variable modifications. Peptide and protein identifications were 
performed automatically with MaxQuant using default settings. Additional option for 
Match between runs and LFQ were selected.  
Label-free DNA oligo pull-down experiments were analyzed using the Perseus (Tyanova 
et al., 2016) version 1.4. Contaminants, hits to the reverse database (reversed) and proteins 
identified only by site were filtered out. LFQ intensity values were logarithmzed and then 
two groups (wild type (WT) and mutated (Mut), with three biological replicates, were 
generated. Protein identifications were filtered to require at least two valid values in at 
least one group. To enable statistical analysis, empty values were imputed with random 
values from the normal peptide intensity distribution, whose mean and standard deviation 
were chosen to best simulate low abundance values close to noise level (width=0.3, down 
shift=1.8). Interacting proteins were identified by performing one-side t-test, comparing 
the WT oligo DNA pull-down versus the Mutate oligo DNA pull-down protein intensities. 
The p-values and the t-test differences were plotted against each other in the volcano plot. 
Proteins with p-value ≤0.05 were selected as putative interactors (Figure 30) 
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5. Results 
 
5.1 A subset of ETS proteins associated with the TSS of housekeeping genes. 
To identify the TFs that control constitutive gene expression in bone marrow-derived 
macrophages (BMDM), we determined the TF consensus DNA binding motifs that are 
statistically overrepresented in the TSS of all genes highly expressed in basal conditions 
(Table 10). In addition to some GC-rich motifs that likely depend on the abundance of 
CpG island-containing promoters in this set of genes, this analysis retrieved (p ≤ 3.6E-246) 
an ETS motif different from the one recognized by the myeloid specific ETS protein PU.1 
(Ghisletti et al., 2010; Heinz et al., 2010). Therefore, a distinct subset of ETS proteins may 
be selectively associated with the TSS of constitutively active genes. 
 
Table 10. Statistical overrepresentation of TF binding sites in macrophages. Pscan analysis was 
performed on constitutively expressed genes (RNA-seq dataset of untreated macrophages from Liv et al., 
2015) versus all TSS.  
Therefore we used ChIP-seq to comparatively explore the genomic distribution of ETS 
proteins highly expressed in macrophages and that based on current annotations (Wei et 
al., 2010) display distinct DNA-binding specificities, namely FLI1 and GABPA (class I), 
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ELF1 and ELF4 (class II), and PU.1 (class III). Some obvious trends were apparent 
irrespective of the threshold used.  
 
 
Figure 7. Genomic distribution of ETS family transcription factors. 
A) Genomic distribution of ELF1, ELF4, GABPa, FLI1 and PU.1 based on ChIP-seq data.  
All peaks were divided into quartiles of progressively higher MACS2 fold enrichment (FE). Peak number is 
indicated on the right of each bin. 
B) TSS-centered analysis of the genomic distribution of ETS family members. 
 
Specifically, ELF1, ELF4 and GABPA showed a significant preference for TSS-proximal 
regions (TSS + 2.5 kb), which was increasingly more evident when considering peaks with 
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a progressively higher score (fold enrichment bins 1 to 4 in Figure 7A). Conversely, PU.1 
showed a strong preference for TSS-distal (inter- and intra-genic) regions, while FLI1 
displayed an intermediate behavior, with ca. 50% of the binding events called at 
intermediate and high stringency being associated with gene promoters (Figure 7A). The 
genomic distribution of the ETS proteins analyzed in genomic windows of +/-10 kb 
surrounding the TSS is shown in Figure 7B.  
A de novo motif discovery analysis (Figure 8) showed that the TSS-associated ETS 
proteins (the class I GABPA and the class II ELF1 and ELF4) recognize a virtually 
identical motif in which the central 5'-GGAA-3' core is preceded by a CC dinucleotide. 
FLI1, even if previously assigned to the same class as GABPA, showed a distinct binding 
preference (with an ACA motif preceding the central core), which likely accounts for its 
different genomic distribution.  The PU.1 motif is the most divergent one and is 
characterized by an extended purine-rich 5' end.  
 
 
Figure 8. ETS motifs (PWMs) identified by de novo motif discovery analysis (MEME).  
the top ranking motifs based on the E values (obtained using MEME) are shown: 4.9e-3395 (FLI1), 1.1e-
2686 (GABPA), 1.2e-3443 (ELF1), 2.8e-3285 (ELF4) and 1.4e-5156 (PU.1).  
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Overall, some ETS proteins (GAPBA, ELF1 and ELF4) have a significant binding 
preference for TSS-proximal regions that correlated with distinct DNA-binding 
specificities that were only partially recapitulated by previous in vitro studies.  
To determine whether differences in genomic distributions reflect distinct functional 
specificities of the ETS proteins analyzed, we used the GREAT tool (McLean et al., 2010). 
GREAT links sets of genomic regions to putative biological functions based on the 
functional annotations of the nearby genes, with a score that is based on the region-gene 
distance and therefore the probability of correct assignment.  
 
Figure 9. ETS proteins target genes belong to different GO categories. 
GO categories associated with different ETS family members as inferred from a GREAT analysis on the 
individual ChIP-seq data sets. 
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When considering the genomic regions bound by ELF1, ELF4 and GABPA, GREAT 
retrieved ontology terms related to housekeeping cellular functions (such as DNA repair, 
RNA metabolism, ribosome biogenesis and protein folding), while ontology terms 
associated with PU.1 and FLI1 clustered separately and were mainly related to myeloid 
cell differentiation and functions (Figure 9). These results are in keeping with the known 
role of PU.1 and FLI1 in macrophage development and indicate that ELF proteins and 
GABPA are likely involved in housekeeping gene regulation.  
Since genes with constitutive expression in macrophages include cell type-specific genes 
and genes with housekeeping functions and broad expression across tissues, we tested 
whether the genes bound by ELFs are expressed in different tissues. To this aim, the 
expression of ELF4-positive genes was evaluated in almost one hundred different tissues 
using publicly available data sets (Tippmann et al., 2012). In all tissues considered (Figure 
10, upper panel), and even more so in hematopoietic cells (Figure 10, bottom panel), 
ELF-associated genes were expressed at significantly higher levels than the ELF-negative 
ones, indicating that irrespective of the cell type, ELF binding correlates with high and 
constitutive gene expression.  
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Figure 10. ELF4 association with the TSS of genes with high expression across tissues.  
Log2 expression intensity of genes bound (green box plots) or not bound (blue box plots) by ELF4 in 
different tissues. Black line represents the median of expression. Cells of the hematopoietic system are 
shown in the lower panel. 
 
Finally, we used a restrictive window of 250pb upstream of TSS to determine the subset of 
ELF4-bound genes expressed at a basal state in macrophages (Austenaa et al., 2015). 81%  
(2524 out of 3117) of ELF4 peaks were associated with the promoters of expressed genes. 
Representative snapshots are shown in Figure 11.  
Overall, these results indicate that a subset of ETS proteins is associated with TSS of 
highly expressed genes, including genes that are broadly expressed across tissues. 
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Figure 11. Representative ChIP-seq snapshot.  
A representative ChIP-seq snapshot of chr.6 showing the distinct genomic distribution of ETS family TFs 
and their relationship with histone marks. 
 
5.2 Association of ELF proteins with the macrophage cis-regulatory 
repertoire. 
We next characterized the features of the TSS-proximal regions associated with the 
promoter-biased ETS proteins (ELFs and GABPA). EDPnew genes were divided in two 
groups based on their association with ELF4 (being ELF4 genomic distribution extensively 
overlapping the one of ELF1, Figure 12) and then analyzed for the occurrence of the 
TATA box and Initiator (INR) motifs, the presence of a CpG island and RNA Pol II 
binding (Figure 13).  
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Figure 12. Overlap between the genomic distribution of ELF1 and ELF4.  
The Venn diagram on the upper panel shows the overlap between ELF4 (light blue) and ELF1 (orange) 
genomic occupancy in unstimulated macrophages. The snapshot on the lower panel shows a representative 
321 kb genomic region on chromosome 8 with multiple ELF1 and ELF4 peaks. 
 
Consistent with previous data (FitzGerald et al., 2004; FitzGerald et al., 2006), ETS sites 
mainly occurred nearby TSS, mapping within 50 nt from annotated TSS. The TATA box 
motif was depleted (but not completely excluded) from the TSS of ELF-bound genes while 
the INR motif showed the opposite trend, being almost absent at ELF-negative TSS. The 
ELF-positive group was dramatically enriched for CpG islands (CpGi) and, consistent with 
the gene expression data shown above, was characterized by much higher constitutive 
levels of RNA Pol II.  
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Figure 13. Preferential binding of ELF proteins to active and GC rich TSS.  
The TSS (+/- 1000 nt) of EDPnew genes were divided in two groups based on ELF4 binding, as indicated. 
The profiles of ELF4 ChIP-seq peaks and motifs are shown together with the profiles of the TATA box and 
INR motifs, CpG islands and Pol II ChIP-seq signal. 
 
An additional and most obvious difference between the two groups became evident when 
analyzing the organization of nucleosomes around the TSS (Barozzi et al., 2014). ELF 
binding was almost invariably associated with intense nucleosome depletion upstream of 
the TSS and strong nucleosome phasing downstream of it, with a particularly prominent 
+1 nucleosome (Figure 14). Differences in nucleosome organization correlate well with 
the different prevalence of CpG islands in the two groups, since a very high G+C content 
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disfavors nucleosome assembly (Barozzi et al., 2014; Fenouil et al., 2012). Overall, ELF 
proteins showed a preference for GC-rich and INR-positive promoters characterized by 
well-defined nucleosome-depleted areas upstream of the TSS.  
 
Figure 14. Preferential binding of ELF proteins to nucleosome-depleted TSS. 
Nucleosome profiles at ELF-positive (left) and ELF-negative (right) TSS. Upper panels show the distribution 
of the midpoints of nucleosomal sequencing fragments centered on the annotated TSS of RefSeq genes. The 
same information is shown below as heatmaps. 
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To expand the analysis of the relationship between ELF proteins and the activity of cis-
regulatory elements, we focused on the genomic regions associated with PU.1, the master 
regulator of the myeloid lineage, which binds and regulates most macrophage-specific 
enhancers and a fraction of the macrophage-specific promoters (Ghisletti et al., 2010; 
Heinz et al., 2010; Mancino et al., 2015). We first used PU.1 binding to map genome-wide 
the macrophage-specific cis-regulatory repertoire and then we divided TSS-distal and 
proximal PU.1-bound regions based on their association with ELFs. At TSS-distal regions, 
ELF binding was associated with levels of H3K27Ac, H3K4me1, RNA Pol II and even 
PU.1 significantly higher than those observed at ELF-negative cis-regulatory elements 
(Figure 15A, upper panels).  
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Figure 15. ELF binding is associated with constitutive activity at macrophage PU.1-bound enhancers 
and promoters. 
A) Cumulative distributions showing H3K4me1 (black), H3K4me3 (grey), H3K27Ac (yellow), PU.1 (green) 
and RNA Pol II (purple) levels of ELF4 positive (ELF4+ve) or negative (ELF4-ve) genomic regions bound 
by PU.1. Data are shown at both distal (top panels) and TSS-proximal (bottom panels) regions. Plots are 
centered on the PU.1 signal and normalized from 0 to 1. B) Box plots showing read density (tags/kb) for the 
indicated ChIP-seq at TSS-distal (left) and TSS-proximal (right) cis-regulatory regions identified by PU.1 
binding. Genomic regions were divided into ELF4 positive and ELF4-negative. 
C) Smoothed scatter plots of PU.1 and ELF normalized motif scores in the same genomic regions are shown 
on the right. Motif scores were measured using FIMO. 
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The correlation between ELF4 binding and marks of high activity was similarly detected at 
PU.1-bound TSS-proximal regions (Figure 15A, bottom panels), where H3K4me3, 
H3K27Ac and RNA Pol II showed higher signals at ELF4-positive than at ELF4-negative 
promoters.  
To gain further mechanistic insight into the relationship between ELF binding and 
underlying sequence features, we scanned the regions in the four groups of regulatory 
elements shown above for the presence of ELF and PU.1 motifs. ELF and PU.1 sites 
tended to co-occur in the PU.1+ve / ELF4+ve regions while the ELF motif was either 
absent or low-scoring in the ELF4-ve regions (Figure 15C), indicating that the regions 
bound by both TFs have a distinct motif composition that correlated with a high activity of 
the underlying cis-regulatory element.  
The box plots in Figure 15B provide a more quantitative description of the same data and 
show the strong correlation between ELF binding and indicators of transcriptional activity. 
 
5.3 Release of ELF proteins from promoters correlates with transcriptional 
shutdown. 
Stimulation of macrophages with inflammatory agonists such as LPS results in the 
transcriptional activation of hundreds of genes as well as widespread gene repression 
(Glass and Natoli, 2016). Therefore, we investigated whether a relationship exists between 
LPS-induced transcriptional changes and ELF binding at gene promoters. LPS stimulation 
for 4 hours resulted in a general reduction in ELF4 occupancy with only a small fraction of 
regions showing increased binding at either TSS (Figure 16A,B) or elsewhere in the 
genome (Figure 16C,D,).  
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Figure 16. Changes in ELF4 genomic distribution upon LPS stimulation correlated with 
transcriptional changes.  
A) The box plot shows changes in ELF4 occupancy at TSS in response to LPS stimulation. B) Scatter plot 
showing changes in genomic occupancy of ELF4 at TSS after LPS stimulation. Invariant, induced and 
repressed peaks are indicated. 
C) Box plot showing ELF4 ChIP-seq tag density (reads/kb) in unstimulated and LPS-stimulated 
macrophages. D) Scatter plot showing changes in ELF4 occupancy at individual genomic regions after LPS 
stimulation. Peaks that were significantly increased (1,849) or reduced (12,325) in response to stimulation 
are highlighted as orange and blue dots, respectively.  
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To determine whether dynamic variations in ELF4 occupancy correlated with gene 
expression changes, we generated datasets of chromatin-associated, nascent transcripts 
from unstimulated and LPS-stimulated (4h) macrophages. In Figure 17A (left panel) 
genes whose transcription significantly changed in response to LPS stimulation (FDR < 
0.01) were ordered, with the most repressed genes on the left side and the most induced 
ones on the right. The smoothed scatter plot in the right panel shows ELF4 binding at the 
corresponding TSS. The overall trend of the plot and the polynomial regression fit (red 
line) indicate a significant albeit imperfect correlation between changes in transcriptional 
activity and ELF4 occupancy, with ELF4 release correlating with transcriptional 
repression and de novo ELF4 binding with gene activation. We also correlated genome-
wide changes in histone acetylation (H3K27Ac) induced by LPS with changes in ELF4 
occupancy. Also in this analysis we detected an imperfect correlation between loss of 
histone acetylation and ELF4 release on the one hand, and gain in acetylation and gain in 
ELF4 occupancy on the other (Figure 17B).  
 
Figure 17. Correlation between transcription changes and ELF4 occupancy. 
Upper panel. In the left panel the genes whose transcription was significantly (FDR<0.01) reduced or 
increased in response to LPS stimulation (based on nascent transcripts) are ordered from left to right. The 
smoothed scatter plot in the right panel shows changes in ELF4 occupancy at the TSS (from -500 to 0) of the 
same genes. The red line represents a polynomial regression fit. Lower panel. Correlation between 
H3K27Ac changes and ELF4 occupancy in LPS-stimulated macrophages. In the left panel all genomic 
regions whose acetylation was significantly reduced or increased in response to LPS stimulation are ordered 
from left to right. The changes in ELF4 occupancy at the same regions are shown on the right. Red line: 
polynomial regression fit.  
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Figure 18 includes two representative genomic snapshots showing ELF4 release from the 
TSS of a repressed gene (Cep55) and ELF4 recruitment to the TSS and an upstream 
transcribed enhancer of an LPS-activated gene (Ccl5).  
 
Figure 18. Representative snapshots. 
Two representative snapshots showing the correlation between ELF binding and transcription at one LPS-
repressed gene (Cep55) and one LPS-activated gene (Ccl5). The sequence upstream of Ccl5 is a broad 
enhancer transcribed upon activation. 
 
Taken together with the data shown above, these results indicate that recruitment of ELF 
TFs tightly correlates with the recruitment of the transcriptional machinery at a broad 
panel of cis-regulatory elements, in both basal and stimulated conditions. 
 
5.4 Functional activity of ETS sites in minimal promoters. 
The strong correlation between ELF binding and constitutive transcriptional activity of 
TSS-proximal and distal cis-regulatory elements, as well as the vicinity of ETS sites to 
mapped TSS, prompted us to explore a direct role of ETS proteins in transcriptional 
activation. Attempts to simultaneously deplete all three ELF proteins expressed in 
	 73	
macrophages (ELF1, ELF2 and ELF4) were not successful and we had to resort to 
alternative strategies. We initially tested a large panel of endogenous core promoters 
consisting in short sequences of fixed length, namely 60 bp from mapped TSS. The 
promoters tested were selected based on the following criteria: i) presence of the canonical 
class II ETS site within 60 nt from the mapped TSS; ii) absence of a TATA box (see 
Figure 13); iii) binding by ELF4 as determined by ChIP-seq. In a first set of experiments, 
all sequences were cloned upstream a common sequence including a single SP1 site and an 
INR sequence (Weis and Reinberg, 1997) in a luciferase vector (pGL3-basic) devoid of 
either promoter or enhancer sequences and thus with very low-to undetectable basal 
activity (Figure 19 and Table 2).  
 
Figure 19. A critical role of ELF-type ETS motifs in the constitutive activity of endogenous promoters. 
Endogenous core promoters (60 nt from annotated TSS) bound by ELF4 in vivo and bearing a canonical ELF 
site were cloned into a promoter-less vector (pGL3-basic, Promega) just upstream a cammon canonical 
initiatior sequence (INR) as indicated. Reporters were transfected in a macrophage cell line (Raw264.7). For 
each promoter a mutation of the ELF site was generated (white bars). Data are shown as fold enrichment 
over promoter-less vector. Error bars: SD of at least three independent biological replicates. 
 
Importantly, the SP1-INR combination alone was ineffective at stimulating luciferase 
expression (Figure 20) while a synthetic promoter in which the SP1 or the INR or both 
motifs were eliminated (Table 6), retained ETS-dependent (albeit lower) transcriptional 
activity. Therefore, the ETS site can efficiently promote transcription in the absence of 
other TF DNA binding sites or canonical core promoter elements. 
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Figure 20. Dissection of the role of INR and SP1 motifs in ELF-dependent transcriptional activation.  
The schematic diagram above shows the organization of individual sequence elements in the reporter vector. 
Fold induction over the empty vector are shown in the histogram. The sequence of the plasmids used is 
shown at the bottom. 
 
Upon transfection in a macrophage cell line (Raw264.7), all the promoters tested 
stimulated the expression of the reporter gene (Figure 19). In 13/17 cases, the 
transcriptional activity of the promoter was almost completely dependent on the ETS site, 
since a mutation destroying two nucleotides in its core abrogated luciferase expression 
(Figure 19, white bars). The same core promoters were not only capable to activate 
transcription in two other non-hematopoietic cell types (hepatocytes and fibroblasts) 
(Figure 21), but they also showed comparable relative strength in the three different cell 
types. Altogether, these data indicate that binding of ETS proteins close to the TSS imparts 
constitutive activity to minimal promoters.  
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Figure 21. Involvement of ELF-type ETS motifs in the constitutive activity of endogenous promoters in 
different cell lines. The same ELF-site positive core promoters sequence as in Fig.19 were tested in 
hepatocytes (HEPA 1-6 cell line) and in fibroblast (L-Wnt-3A). 
 
Importantly, core promoter activity strictly required an ELF-type ETS site because its 
replacement with a PU.1 site (Figure 22) in nearly all cases (8 / 10) abrogated 
transcriptional activity.  
 
Figure 22. PU.1-type ETS motif drives low expression of endogenous promoters.   
The ELF-site of a panel of core promoter sequences shown in Fig.19 was mutated to PU.1 site (white bars) 
and the effects on luciferase activity were measured. Error bars: SD of at least three independent biological 
replicates.  
 
Since ELFs also bound to active enhancers via their specific motifs (Figure 15) we 
investigated whether ELF site-containing enhancers were similarly capable of activating 
transcription. 60 bp-long DNA fragments corresponding to ELF4-positive enhancers were 
cloned (Table 3) and tested as described above: all enhancers tested were able to activate 
transcription of the reporter gene (Figure 23). 
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Figure 23. Transcriptional activity of ELF4-positive enhancers.  
Enhancers bound by ELF4 and containing an ELF site were tested for their capability to act as core 
promoters in macrophages. 60 nt regions (+/- 30 bp from ETS summit) were cloned and tested as described 
in Fig.19. Red line indicated a 1 fold enrichment over pGL3-basic vector.  
 
Given the data above, it was critical to determine if ELF sites in endogenous promoters in 
their own native genomic context are similarly required to activate gene transcription. 
Therefore we resorted to CRISPR/Cas9-mediated genome editing, taking advantage of the 
fact that the core ETS site (NGGAA) contains the PAM sequence of SpCas9 (NGG). We 
selected five genes containing a TSS-proximal ETS site and generated individual clones 
that were sequenced to identify small and mechanistically informative mutations. For two 
genes (Cep55 and Fuz) we obtained several clones in which both alleles were properly 
mutated. In all cases, mutations affecting the ETS site (even if removing a single 
nucleotide) almost completely abrogated the expression of the adjacent gene (Figure 24). 
Overall, a subset of ETS sites bound by ELF proteins was necessary and sufficient to 
impart high and constitutive transcriptional activity to a broad panel of cis-regulatory 
elements. 
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Figure 24. ELF-type ETS sites involvement in the transcriptional activity in the native genomic 
context.  
CRISPR/Cas9 was used to edit genomic sequences spanning the TSS-proximal ELF site at two genes 
constitutively bound by ELF4. Individual Raw246.7 clones were isolated and sequenced to characterize the 
mutant sequences at each allele of the two genes. The histogram on the left shows mRNA expression by RT-
qPCR in wild type cells (transduced with Cas9 without sgRNA) and in a selected panel of clones bearing 
informative mutations sapanning the ELF site. The sequence of the mutant clones is shown on the right. The 
ELF site is shown in red and underlined.   
 
5.5 Mutual interactions between ELF proteins and the transcriptional 
machinery. 
Since the ETS sites recognized by ELFs and GABPA are commonly found within 50 nt 
(and even more frequently within 20 nt) from mapped TSS (FitzGerald et al., 2004; 
FitzGerald et al., 2006), we determined the impact on transcriptional activation of the 
distance between the ETS site and the INR sequence. First, ELF motif-containing 
promoters (n = 51) were divided into 5 groups based on the distance between the ETS site 
and the TSS (listed in Table 1). 60 bp fragments were then cloned upstream of a common 
SP1-INR motif as above (Figure 19) and tested for luciferase activity. The median 
transcriptional activity of these fragments correlated with the distance of the ETS site from 
the TSS, with a shorter distance being generally associated with a higher transcriptional 
activity (Figure 25A). To analyze the effects of the distance between the ETS site and the 
INR in an identical sequence context, we created a synthetic 60 nt-long core promoter 
based on a transcriptionally inert backbone from a bacterial plasmid, in which we inserted 
	 78	
an ELF type ETS site at variable distances from the INR (Table 5). The combination of an 
ETS site and the INR was sufficient to activate luciferase expression in this minimal 
promoter context (Figure 25B). Moreover, also the synthetic promoter showed a clear 
(albeit imperfect) trend where a smaller distance of the ETS site from the INR was 
associated with higher activity (Figure 25B). Also in this synthetic promoter the 
replacement of the ELF/GABPA site with a PU.1 site caused a loss of activity. 
 
Figure 25 Correlation between ELF-type site and its distance from TSS. 
A) Endogenous ELF site-positive core promoters (n=51) as described in Fig.19 were divided into 5 groups 
depending in the distance from TSS and tested for luciferase activity in macrophages. Each dot of the 
beeswarm plot represents one biological replicate out of three independent experiments. The central red bars 
indicate the median, the grey bars the 1st and 3rd quartile. Data are shown as fold enrichment over promoter-
less vector (pGL3-basic). B) Synthetic sequences containing an ELF-site (red) or  a PU.1 site (blue) at 
different distances from a common initiatior sequence (INR, green) were tested for luciferase activity in 
macrophages. Data are shown as fold enrichment over promoter-less vector (pGL3-basic). Error bars 
represent +/-SD of at least three independent biological replicates.  
 
The data shown above hint at the occurrence of close interactions between ETS site-bound 
proteins and the transcriptional machinery. Therefore we tested if the transcriptional 
machinery, once recruited to promoters, stabilizes the association of ETS proteins with 
their DNA-binding site. To this aim we depleted the large RNA Pol II subunit (Rbp1) with 
an extended (5h) treatment with a-amanitin (Figure 26A) and we generated ELF4, 
GABPA and PU.1 ChIP-seq datasets (Figure 27).  
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Figure 26. Effects of alpha-amanitin treatment on ELF4 genomic occupancy.  
A) Rpb1 and ELF4 western blots in untreated and a-amanitin-treated macrophages. n.s.: non-specific band. 
B) Box plot showing ATAC-seq read density (tags/kb) in untreated and a-amanitin-treated macrophages. C) 
The scatter plot shows ATAC-seq read density in untreated and a-amanitin treated macrophages. Unaffected 
peaks are indicated as grey dots. 
 
While RNA Pol II depletion did not greatly impact PU.1 and GABPA association with 
TSS-proximal regions, it nearly completely (7745 / 7902 peaks, 98%) abrogated ELF4 
binding (Figure 27) without affecting its abundance (Figure 26A). The effects of a-
amanitin on ELF4 binding were not associated with differences in promoter accessibility, 
as indicated by an ATAC-seq analysis (Figure 26B and C). 
 
Figure 27. Relationship between TSS-proximal ELF4 binding and the transcriptional machinery.  
Scatter plot indicating genomic regions (+/- 1000 bp from TSS) bound by ELF4 (left panel), GABPa (middle 
panel) and PU.1 (right panel) as determined by ChIP-seq in macrophages treated with alpha-amanitin (5h, 
10ng/mL) relative to untreated cells (UT). Blue dots indicate regions where ELF4 signal is reduced upon 
alpha-amanintin treatment.  
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These data show that binding of ELF4 (but not GABPA or PU.1) to active TSS-proximal 
regions is stabilized by RNA Pol II, which is likely an indirect evidence of a close physical 
interaction between components of the transcriptional machinery and DNA-bound ELF 
proteins. A representative snapshot is shown in Figure 28.  
 
Figure 28. Representative snapshot. 
A representative genomic region showing ELF4 binding loss upon alpha-amanitin treatment, while GABPa 
and PU.1 binding are not affected. 
 
 
5.6 ETS-dependent recruitment of transcriptional and chromatin regulators to 
core promoters. 
To obtain insight into the mechanism of action of ELF proteins in transcriptional 
activation, we used a DNA affinity purification approach coupled to mass spectrometry 
analysis. Briefly, we terminally labeled with biotin a 240 nt DNA fragment (-150/+50 
relative to the annotated TSS) corresponding to the Scamp2 gene promoter, which contains 
a canonical ELF site and is efficiently bound in vivo (Figure 29).  
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Figure 29. Snapshot and experimental scheme. 
On the left is shown the snapshot of the Scamp2 gene showing TSS-proximal ELF1 and ELF4 binding. The 
TSS (red) and the ELF site (light blue, underlined) are highlighted in the DNA sequence below. On the right 
is shown the experimental scheme of the DNA-mediated pull-down experiment using baits containing either 
a wild-type (WT) or a mutated (Mut) ETS motif, in a label-free experiment. Unlabeled nuclear extract was 
incubated in parallel with biotin-conjugated oligos, either wild-type (left) or mutated (right) in the ETS site. 
Proteins from the two individual experiments were analyzed separately by high-resolution LC-MSMS. 
Proteins in each sample were quantified with label-free algorithm contained in the MaxQuant software suite, 
whereby the intensity of corresponding peptides are compared between individual spectra. Specific 
interactors (i.e. blue line) show a higher LFQ intensity value in the WT than in the Mut pull-down, where 
binding is reduced or abrogated due to the mutation in the ETS site. Peptide peaks from background proteins 
(i.e. red line), instead, have equal LFQ intensity in the two experiments, with no effect of the mutation.  
 
As a control, we generated a probe with a point mutation in the ELF site. Triplicate 
experiments were set up in which wild type and mutant probes were separately incubated 
with a nuclear lysate. Biotinylated DNA fragments were retrieved with streptavidin 
paramagnetic beads and extensively washed before analyzing bound proteins by label-free 
mass spectrometry (Figure 29). 
We identified 1353 proteins, the majority (1149/1353, 84.9%) of which were equally 
pulled down using the wild type or the ETS sites mutant probe. The 204 proteins 
specifically enriched in the pull-down with the wild type probe were considered putative 
ELF interactors (Figure 30).  
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Figure 30. Identification of proteins recruited to core promoters in an ELF-dependent manner.  
A) Overlap of proteins identified -with at least two peptides (peptides >1) of which at least one unique 
(unique >0)- among the 3 pull-down experiments carried out with wild type (WT) biotinylated oligo DNA. 
B) Volcano plot of ELF interactors; the proteins significantly enriched in the WT oligo DNA relative to the 
mutated oligo DNA pull-downs are above the grey line (one-side t-test p-value ≤0.05). Some transcriptional 
co-regulator proteins are highlighted. 
 
In addition to the retrieval of ETS proteins (ELFs and FLI1), we identified a number of 
proteins involved in different aspects of transcriptional regulation (Figure 30 and 31), 
including chromatin remodelers (BAF57 and CHD1) and proteins affecting RNA Pol II 
processivity (NELFB, the integrator complex subunit INTS10, PRMT5 and CSTF1/2). 
NELFB and Integrator complex subunits interact to control RNA Pol II release from 
promoter proximal pausing (Gardini et al., 2014; Stadelmayer et al., 2014) and enable 
productive transcriptional elongation. CHD1 was previously shown to bind the TSS of 
highly active genes and to remove the nucleosomal barrier downstream of the TSS, thus 
enabling RNA Pol II promoter escape (Skene et al., 2014) and maintaining high-level 
transcription (Guzman-Ayala et al., 2015).  
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Figure 31. ELF-mediated recruitment of transcriptional and chromatin regulators to core promoters.  
Upper panel. Shortlist of putative ELF interactors. The ratio value (calculated dividing the LFQ intensity of 
each proteins in WT oligo DNA PD over the mutated oligo DNA PD) is reported for each protein in all 
biological replicates. ∞ indicates ratio where the LFQ intensity of a protein was equal to 0 in the mutated 
oligo DNA PD; nd: not detected protein. Proteins significantly enriched are indicated with their respective p-
values. The other proteins indicated were not statistically significant but present in at least two out of three 
biological experiments in the Top 30% of each independent LFQ proteins ratio distribution. Lower panel. 
Western blot analysis of selected proteins pulled down in the affinity purification experiments with wild-type 
(WT) and mutated (MUT) baits. Arrowheads indicate specific bands. PD: Pull-down, FT: Flow-through. 
 
We first validated some of the affinity-isolated proteins by western blot in independent 
experiments. ELF4 was used as a specific control and in fact it was selectively pulled 
down with the wild type probe (Figure 31). NELFB, INTS10 and CHD1 were relatively 
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enriched in affinity purifications with the wild type probe (Figure 31), with ratios that 
were overall consistent with those observed in the mass spectrometry analysis. In 
particular, recruitment of INTS10 was very selectively dependent on an intact ELF site.  
 
Figure 32. ELFs absence impact on nascent RNA expression, RNA Pol II recruitment and H3K27ac 
deposition. 
A) Nascent (chromatin-associated) transcripts at the Cep55 gene in wild type and ETS site mutant Raw264.7 
cells. Numbers (relative to the mapped TSS) correspond to the PCR amplicon. The grey line represents the 
TSS. B) Snapshot of the Cep55 gene from a total RNA Pol II ChIP-seq in wild type and ETS site mutant 
Raw264.7 cells. The normalized reads corresponding to the paused (promoter-proximal) RNA Pol II peak 
and to the gene body, are indicated. C) Histone H3K27 acetylation at the Cep55 gene in cells with a wild 
type or mutant ETS site. The grey line represents the TSS. 
 
The ELF-dependent association of proteins controlling promoter escape of RNA Pol II 
(CHD1) and transcriptional elongation (NELFB and Integrator) prompted us to further 
characterize the functional consequences of ETS site editing at the Cep55 gene (Figure 
24). Since we found that nascent RNAs were down-regulated all over the gene body 
(Figure 32A), we performed an RNA Pol II ChIP-seq to discriminate between elongation 
and initiation defects. This analysis revealed a similar occupancy of the TSS-proximal 
region by the paused RNA Pol II regardless of ETS site mutation, but a 2.9-fold reduction 
in the number of intragenic reads (Figure 32B), indicating a defective entry of RNA Pol II 
inside the coding region. Remarkably, histone acetylation downstream of the TSS was 
almost completely abrogated in ETS site-mutant cells (Figure 32C).
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6. Discussion 
 
The functional specificity of the thousands of cis-regulatory elements that control the 
transcriptional output of higher eukaryotic cells is determined by the characteristic 
combination and arrangement of TF motifs that eventually establish the unique profile of 
activity of each one of them (Farley et al., 2015). The focus of this study was the repertoire 
of constitutively active enhancers and promoters, with the objective of identifying the 
possible existence of shared molecular determinants of their high activity. The data we 
obtained suggest that irrespective of their role in housekeeping or tissue-specific 
transcription, a large panel of constitutively active promoters and enhancers may rely on a 
more limited number of broadly used TFs (such as the ELF proteins) than could in 
principle be expected based on their functional divergence.   
ETS proteins are a large family of TFs whose first identifiable ancestor is IBP39, a 
protein that in the primitive eukaryote Trichomonas vaginalis binds both the Inr core 
promoter motif and RNA Pol II (Schumacher et al., 2003). Therefore ETS proteins may 
have originally evolved as molecular bridges between core promoters and the 
transcriptional machinery, thus directly enabling early steps in transcription. The data 
reported in this study suggest that while some ETS proteins (such as PU.1 and FLI1) 
acquired in mammals tissue-specific functions mainly related to enhancer specification 
(Ghisletti et al., 2010; Heinz et al., 2010; Lichtinger et al., 2012), some others (such as 
ELFs and GABPA) may have retained ancestral functions related to core promoter 
regulation and specifically to the maintenance of the high activity of a subset of 
transcriptionally competent enhancers and promoters. Such functional differences among 
ETS family members are reflected by the fine specificity of the DNA motifs recognized by 
each one of them, which results in completely different genomic distribution profiles, with 
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enhancer-biased and promoter-biased ETS proteins at the two opposite ends of the 
spectrum.  
The tight link between ELF proteins and efficient transcription is underscored by 
the fact that the relatively small fraction of bound enhancers was also the one with by far 
the strongest activity (as inferred by both histone acetylation and RNA Pol II levels). The 
close proximity of ELF-specific ETS sites to the TSS and the negative impact of RNA Pol 
II depletion on ELF occupancy, are both consistent with the occurrence of a tight 
interaction between DNA bound ELFs and the transcriptional machinery. However, the 
precise step(s) at which promoter-associated ETS proteins act to control transcription will 
require additional investigation. Our proteomic and genomic data hint at a role of ELFs in 
the control of transcriptional elongation rather than initiation. Specifically, RNA Pol II 
density in the body of a gene with a mutated TSS-proximal ETS site was strongly reduced 
while loading at the TSS was not or was only marginally affected. The identification of 
NELF and an Integrator complex subunit as ELF interactors is consistent with a direct 
impact of TSS-proximal ELFs on promoter escape by RNA Pol II. Moreover, recruitment 
of the chromatin remodeler CHD1, which removes intragenic, promoter-proximal 
nucleosomes (Skene et al., 2014) may critically contribute to transcriptional elongation at 
genes (such as those bound by ELFs, Figure 14) with a prominent +1 nucleosome. 
However, additional mechanisms linking ELFs to transcriptional control and specifically 
to RNA Pol II recruitment and initiation cannot be ruled out, particularly considering that 
unstable and weak interactions may have been overlooked by the affinity purification 
strategy we used. In fact, the sufficiency at activating transcription of a minimal synthetic 
promoter containing only an ELF site and no strong core promoter elements points to 
direct interactions with the transcriptional machinery that may by themselves be sufficient 
to recruit RNA Pol II and initiate transcription. 
The general principle that can be drawn from these data is that the cooptation of a 
limited number of TFs (such as the ELFs) capable of strongly facilitating transcription may 
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represent a transversal strategy broadly adopted across cell types to equip cis-regulatory 
elements with disparate functional roles and specificity with the ability to efficiently 
promote transcription. Conversely, the absence of the same motifs in a cis-regulatory 
region may represent a pre-requisite for its tighter regulation in response to specific micro-
environmental or developmental cues. Overall, when considering cell type-specific cis-
regulatory elements, the emerging paradigm is that they are generated by a combination of 
motifs recognized by tissue-restricted TFs (commonly endowed with the ability to displace 
nucleosomes and generate accessible chromatin)(Glass and Natoli, 2016; Zaret and 
Carroll, 2011) and motifs for TFs that impart specific functional properties such as 
inducible (e.g. NF-kB, AP-1) or constitutive (such as ELFs) activity to that specific 
element. Finally, the data shown in our study contribute to provide a mechanistic 
framework for previous observations linking ubiquitously or broadly expressed TFs to 
critical tissue-restricted functions (Gilmour et al., 2014). 
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